Rosacea

L12_ROSACEA

rosacea: a chronic skin condition characterized by facial redness, small and superficial dilated blood vessels on facial skin, papules, pustules, and swelling.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L71 Cause of death: ICD-10 — L71 2 out of 7 registries used, show all original rules.	4968
4. Check minimum number of events None	4968
5. Include endpoints L12_PERIORALDERM L12_RHINOPHYMA L12_ROSACEANAS	4999
6. Filter based on genotype QC (FinnGen only)	4875

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L60-L75
Name in latin: Rosacea

NAME	L12_ROSACEA
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_PERIORALDERM\|L12_RHINOPHYMA\|L12_ROSACEANAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L71
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L71
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Rosacea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4875	3562	1313
Unadjusted period prevalence (%)	1.09	1.26	0.60
Median age at first event (years)	55.21	52.59	62.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4999: Matched controls
49990

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L71

ICD-10 Finland

Rosacea

31.1

307.7

1119

459

J01AA04

ATC

lymecycline; systemic

10.2

307.7

2256

3724

D10BA01

ATC

isotretinoin; oral

8.7

307.7

994

1393

J01AA07

ATC

tetracycline; systemic

7.0

307.7

2048

4491

D10AX03

ATC

azelaic acid; topical

5.4

307.7

893

1949

L71.0

ICD-10 Finland

Perioral dermatitis

40.7

307.7

938

282

E0000UV, ,

ATC

3.4

307.7

3009

15346

D06BX01

ATC

metronidazole; topical

28.7

307.7

3268

3085

L71.8

ICD-10 Finland

Other rosacea

242.0

307.7

1925

129

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.0

307.7

951

2223

L71.9

ICD-10 Finland

Rosacea, unspecified

130.4

307.7

2351

338

XQ802

NOMESCO Finland

Epicutan test

6.0

284.6

540

991

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.1

284.2

1600

6510

L71.1

ICD-10 Finland

Rhinophyma

573.1

223.2

220

E000001, ,

ATC

2.8

205.2

1417

6284

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.4

202.9

836

2767

L70.0

ICD-10 Finland

Acne vulgaris

9.9

189.9

222

234

L57.0

ICD-10 Finland

Actinic keratosis

3.5

186.9

721

2282

XQ848

NOMESCO Finland

Dermatological photography

6.5

179.0

304

496

XQ800

NOMESCO Finland

Prick test

3.3

150.5

633

2102

D07AB02

ATC

hydrocortisone butyrate; topical

2.2

149.7

1817

10167

L73.8

ICD-10 Finland

Other specified follicular disorders

19.9

146.4

113

D07AC01

ATC

betamethasone; topical

2.1

135.2

2101

12823

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

6.3

128.9

221

363

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

8.6

122.4

158

189

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

120.4

2391

15745

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.2

117.7

1371

7417

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

6.0

113.8

204

350

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

110.9

788

3440

D07AC13

ATC

mometasone; topical

2.0

110.5

1675

9957

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.4

100.9

829

3854

D07AB08

ATC

desonide; topical

2.5

98.0

691

2994

S01GX01

ATC

cromoglicic acid; ophthalmic

2.1

97.6

1259

7008

H01.0

ICD-10 Finland

Blepharitis

2.9

94.6

473

1719

D07XC01

ATC

betamethasone; topical

2.4

90.5

719

3282

D07AD01

ATC

clobetasol; topical

2.1

90.1

999

5234

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.7

89.8

213

469

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.3

86.4

179

351

TQW80

NOMESCO Finland

Local dermatologic skincare

4.5

85.9

213

486

H02AB06

ATC

prednisolone; systemic

1.8

83.0

2477

17826

L20.0

ICD-10 Finland

Besnier prurigo

2.6

80.9

500

2025

E0001A1, ,

ATC

4.9

79.8

179

376

R06AX27

ATC

desloratadine; oral

1.8

78.4

1657

10729

D10AF01

ATC

clindamycin; topical

3.1

77.1

347

1185

L73.2

ICD-10 Finland

Hidradenitis suppurativa

14.8

74.2

D07AA02

ATC

hydrocortisone; topical

2.1

73.7

794

4086

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.3

73.7

289

909

R06AE07

ATC

cetirizine; oral

1.7

72.4

2389

17445

ZXC12

NOMESCO Finland

Pulse colorlaser

15.2

71.7

XQ845

NOMESCO Finland

Dermatoscopy

5.2

70.9

148

292

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.2

70.2

288

931

L04AX01

ATC

azathioprine; systemic

3.1

69.1

296

981

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

68.9

1641

10914

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.5

68.4

449

1867

ZXC50

NOMESCO Finland

Cryotherapy

4.0

68.0

200

519

E000002, ,

ATC

2.2

67.1

649

3194

D02AE01

ATC

carbamide; topical

2.6

66.7

405

1621

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

11.7

66.3

J02AC01

ATC

fluconazole; systemic

1.7

65.3

2274

16687

D11AH02

ATC

pimecrolimus; topical

10.9

63.5

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

7.0

60.5

133

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

59.6

1436

9506

D02AX

ATC

Other emollients and protectives

3.4

59.0

216

650

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.7

58.7

334

1292

S29

ICPC

Skin symptom/complaint other

1.8

58.7

991

5911

L04AX03

ATC

methotrexate; systemic

2.2

58.5

566

2779

H00.1

ICD-10 Finland

Chalazion

3.1

58.2

253

845

J01DB01

ATC

cefalexin; oral

1.9

58.0

4144

36128

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

5.9

57.9

105

182

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.8

57.7

302

1119

L93.0

ICD-10 Finland

Discoid lupus erythematosus

9.0

57.5

L21.0

ICD-10 Finland

Seborrhoea capitis

6.4

57.5

150

UJF32

NOMESCO Finland

Coloscopy

1.7

56.5

1276

8277

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

55.1

278

1009

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.1

54.1

539

2672

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

54.1

1005

6154

L73.9

ICD-10 Finland

Follicular disorder, unspecified

12.1

53.9

P01BA02

ATC

hydroxychloroquine; oral

2.2

53.9

494

2370

R06AE09

ATC

levocetirizine; oral

1.9

53.5

815

4693

L70.8

ICD-10 Finland

Other acne

21.8

52.5

S18

ICPC

Laceration/cut

1.6

48.2

2137

16221

L70.9

ICD-10 Finland

Acne, unspecified

9.3

47.4

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

4.2

47.2

125

300

L82

ICD-10 Finland

Seborrhoeic keratosis

1.8

46.5

899

5542

L04AA06

ATC

mycophenolic acid; systemic

4.2

46.5

127

312

L70

ICD-10 Finland

Acne

4.6

45.7

110

245

J01AA02

ATC

doxycycline; systemic

1.6

44.5

3839

33498

L50.3

ICD-10 Finland

Dermatographic urticaria

3.8

44.2

135

360

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

44.1

1126

7472

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

43.9

344

1543

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

43.6

1267

8680

E000006, ,

ATC

2.2

43.2

379

1781

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

42.1

217

796

SPAT1153

SPAT

Removal of sutures

1.6

41.6

1462

10450

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

11.1

41.5

L30.8

ICD-10 Finland

Other specified dermatitis

3.2

41.5

168

538

E000007, ,

ATC

2.3

41.4

315

1394

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

39.6

2030

15690

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

4.7

39.2

193

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.6

38.7

203

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

38.4

642

3776

A02BC05

ATC

esomeprazole; systemic

1.5

36.8

1964

15231

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

36.8

561

3206

R03AC02

ATC

salbutamol; inhalant

1.5

36.0

2686

22182

J04BA02

ATC

dapsone; oral

8.1

35.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

35.7

1539

11417

L30.3

ICD-10 Finland

Infective dermatitis

2.7

35.7

197

749

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.9

35.5

161

D05AX52

ATC

calcipotriol, combinations; topical

2.3

35.1

278

1251

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

35.0

370

1867

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

34.8

821

5301

M79.6

ICD-10 Finland

Pain in limb

1.5

34.3

2023

15931

S99

ICPC

Skin disease other

3.4

34.2

125

376

L72.1

ICD-10 Finland

Trichilemmal cyst

2.3

33.8

252

1105

S01XA18

ATC

ciclosporin; ophthalmic

5.5

33.6

120

J05AB01

ATC

aciclovir; systemic

1.6

33.2

1074

7474

R06AX22

ATC

ebastine; oral

1.6

32.8

885

5903

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

32.4

129

409

J01DA01

ATC

[U] cefalexin

1.4

32.4

2960

25150

S21

ICPC

Skin texture symptom/complaint

1.7

32.1

657

4080

L21

ICD-10 Finland

Seborrhoeic dermatitis

3.7

32.1

104

289

J01FF01

ATC

clindamycin; systemic

1.5

32.1

1251

9052

D11AH01

ATC

tacrolimus; topical

4.5

31.9

172

M25.5

ICD-10 Finland

Pain in joint

1.5

31.4

1585

12064

D05BB02

ATC

acitretin; oral

3.2

31.3

123

387

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.8

31.2

253

R01AD58

ATC

fluticasone, combinations; nasal

1.5

31.1

1243

9033

J02AC02

ATC

itraconazole; systemic

1.6

31.0

888

5997

A02BC01

ATC

omeprazole; systemic

1.5

31.0

1240

9010

R01AD12

ATC

fluticasone furoate; nasal

1.5

30.9

1599

12220

CBB00

NOMESCO Finland

Excision of chalazion

4.0

30.9

219

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.2

30.0

121

387

A02BC02

ATC

pantoprazole; systemic

1.4

29.6

3218

27969

H02AB07

ATC

prednisone; oral

1.7

29.4

633

3980

A02BC03

ATC

lansoprazole; oral

1.5

29.3

1295

9580

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

29.3

848

5735

R03DC03

ATC

montelukast; oral

1.6

28.8

833

5629

J01FA10

ATC

azithromycin; systemic

1.4

28.2

2811

23967

D06BB10

ATC

imiquimod; topical

2.2

28.1

248

1166

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

27.6

1742

13735

SPAT1310

SPAT

Counselling related to known health issue

1.4

27.3

1433

10930

R01AD09

ATC

mometasone; nasal

1.4

27.1

2219

18262

H02AB04

ATC

methylprednisolone; systemic

1.6

27.0

681

4449

R01AD08

ATC

fluticasone; nasal

1.4

27.0

1387

10528

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

26.8

589

3719

J01FA01

ATC

erythromycin; systemic

1.6

26.7

677

4430

C01CA24

ATC

epinephrine; parenteral

1.9

26.5

330

1762

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

26.5

415

2384

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

26.5

244

1168

L04AA01

ATC

[U] ciclosporin

3.7

26.4

226

L04AD01

ATC

ciclosporin; systemic

3.2

26.4

105

333

R06.0

ICD-10 Finland

Dyspnoea

1.5

26.3

1157

8523

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

26.2

1206

8960

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

26.2

479

2877

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

26.1

1215

9046

R06AX13

ATC

loratadine; oral

1.6

26.0

743

4998

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.5

26.0

B07.9

ICD-10 Finland

Verruca simplex

2.4

25.8

184

791

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.1

25.5

173

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

25.5

308

1628

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

4.7

25.4

124

H00.00

ICD-10 Finland

Hordeolum

2.2

25.4

227

1073

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.6

25.2

133

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

25.1

1835

14768

K30

ICD-10 Finland

Functional dyspepsia

1.7

24.9

541

3403

R05

ICD-10 Finland

Cough

1.5

24.8

981

7065

S01GX05

ATC

lodoxamide; ophthalmic

3.4

24.8

260

H15.1

ICD-10 Finland

Episcleritis

3.3

24.8

285

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

24.7

3217

28344

S08

ICPC

Skin colour change

2.0

24.5

255

1278

J01FA06

ATC

roxithromycin; oral

1.4

24.4

1850

14954

J01MA02

ATC

ciprofloxacin; systemic

1.4

24.3

1666

13246

L01XX05

ATC

hydroxycarbamide; oral

4.0

24.3

175

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.6

24.2

221

L50.9

ICD-10 Finland

Urticaria, unspecified

2.3

24.2

195

884

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

24.0

223

1070

L04AB04

ATC

adalimumab; parenteral

2.7

24.0

126

468

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

23.8

1904

15505

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

23.7

1378

10647

F29

ICPC

Eye symptom/complaint other

1.7

23.7

439

2645

J05AB11

ATC

valaciclovir; oral

1.6

23.6

678

4558

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

23.6

2357

19863

SPAT1263

SPAT

Sampling

1.4

23.4

1885

15358

N02BE01

ATC

paracetamol; systemic, rectal

1.5

23.4

4301

40037

N02AX02

ATC

tramadol; systemic, rectal

1.4

23.3

1880

15319

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

22.9

1331

10270

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.8

22.9

183

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

22.8

292

1572

L20

ICD-10 Finland

Atopic dermatitis

2.4

22.8

155

653

L30.0

ICD-10 Finland

Nummular dermatitis

2.3

22.7

177

792

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

2.7

22.5

121

455

SPAT1301

SPAT

No procedures

1.4

22.4

1337

10361

SPAT1312

SPAT

General health counselling

1.4

22.3

1408

11008

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

22.3

164

715

D01AE16

ATC

amorolfine; topical

1.6

22.0

508

3241

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

21.9

466

2912

E000003, ,

ATC

2.1

21.8

209

1016

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

21.8

566

3715

C07AA05

ATC

propranolol; systemic

1.5

21.8

954

6990

L01

ICPC

Neck symptom/complaint

1.5

21.7

738

5141

G47.3

ICD-10 Finland

Sleep apnoea

1.5

21.7

939

6863

R60.0

ICD-10 Finland

Localized oedema

1.6

21.6

510

3272

SPAT1260

SPAT

Consultation of another employee

1.5

21.6

759

5326

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

21.5

3450

31014

L43.8

ICD-10 Finland

Other lichen planus

2.9

21.4

338

R51.80

ICD-10 Finland

Headache

1.5

21.4

737

5149

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

21.3

277

1499

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

3.7

21.3

183

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

21.3

1784

14567

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

4.5

21.0

111

G03HB01

ATC

cyproterone and estrogen; oral

1.6

21.0

496

3182

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

6.5

20.9

6953A

ICD-9 Finland

Erythematous conditions, Rosacea[ROSACEA]

+∞

20.8

I73.0

ICD-10 Finland

Raynaud syndrome

2.9

20.7

345

M01AH05

ATC

etoricoxib; oral

1.3

20.5

2919

25681

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.2

20.5

257

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.0

20.4

299

L50.8

ICD-10 Finland

Other urticaria

2.8

20.4

104

381

A07EA06

ATC

budesonide; oral, local oral

2.2

20.3

179

842

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

20.3

1232

9544

Z01.2

ICD-10 Finland

Dental examination

1.3

20.0

2122

17884

D06AX01

ATC

fusidic acid; topical

1.7

20.0

410

2536

S01

ICPC

Pain/tenderness of skin

2.0

20.0

213

1077

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

19.9

541

3585

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

19.8

354

2109

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

19.8

313

1801

R06AX26

ATC

fexofenadine; oral

1.7

19.7

341

2014

D06BX02

ATC

ingenol mebutate; topical

3.6

19.6

184

127

Kela drug reimbursment

Transplant complication

3.3

19.6

228

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

19.6

830

6030

S06

ICPC

Rash localized

1.9

19.6

242

1288

L70.1

ICD-10 Finland

Acne conglobata

40.2

19.5

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

19.5

361

2173

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

19.4

172

811

A01AB09

ATC

miconazole; local oral

1.7

19.4

366

2214

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

19.3

504

3308

M54.5

ICD-10 Finland

Low back pain

1.3

19.3

1642

13390

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

19.2

291

1653

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

19.2

439

2791

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

19.2

307

1772

Z00.0

ICD-10 Finland

General medical examination

1.4

19.1

812

5903

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

19.0

302

1739

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.8

19.0

333

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

19.0

2197

18694

L17

ICPC

Foot/toe symptom/complaint

1.4

18.8

1245

9765

D07XB05

ATC

dexamethasone; topical

2.4

18.5

124

519

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

18.5

171

820

L03

ICPC

Low back symptom/complaint

1.4

18.5

1249

9823

J01DA09

ATC

[U] cefadroxil

1.4

18.4

1189

9280

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

18.3

1398

11194

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.4

18.3

123

516

M03BX02

ATC

tizanidine; oral

1.3

18.3

2946

26157

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.9

18.3

228

1218

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

18.2

1155

8991

ZY010

NOMESCO Finland

Hospital outpatient

1.9

18.0

232

1252

N03AX16

ATC

[U] pregabalin

1.4

18.0

1009

7692

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

17.9

572

3923

F03

ICPC

Eye discharge

1.8

17.9

301

1764

N03AX12

ATC

[U] gabapentin; oral

1.5

17.8

717

5154

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

17.8

344

2095

A07EC02

ATC

mesalazine; oral, rectal

1.9

17.8

241

1323

69530

ICD-8 Finland

Erythematous condition, Rosacea

+∞

17.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

17.7

395

2497

R53

ICD-10 Finland

Malaise and fatigue

1.4

17.5

1033

7936

M01AE02

ATC

naproxen; oral, rectal

1.3

17.5

2638

23149

Z94.0

ICD-10 Finland

Kidney transplant status

3.7

17.4

151

SDA03

NOMESCO Finland

Periodontal treatment

1.3

17.4

1848

15488

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.5

17.3

111

456

R03BA02

ATC

budesonide; inhalant

1.4

17.3

798

5878

J01FA09

ATC

clarithromycin; systemic

1.3

17.3

1433

11599

G44.2

ICD-10 Finland

Tension-type headache

1.5

17.2

645

4569

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

17.2

200

1043

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

17.2

335

2043

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

17.1

572

3959

Z3231

NOMESCO Finland

Registered nurse

1.4

17.1

1123

8773

D45

ICD-10 Finland

Polycythaemia vera

3.9

17.1

130

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

16.9

415

2683

S01GX08

ATC

ketotifen; ophthalmic

1.9

16.9

220

1192

A98

ICPC

Health maint/preventive medicine

2.0

16.8

4832

46803

A02BA02

ATC

ranitidine; systemic

1.4

16.8

772

5682

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

16.7

350

2176

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

16.7

186

957

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

16.7

822

6125

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

16.6

209

1120

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

16.6

170

848

N06AX11

ATC

mirtazapine; oral

1.3

16.6

1487

12153

L40

ICD-10 Finland

Psoriasis

2.6

16.6

376

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.6

16.5

382

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

3.6

16.5

152

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

16.5

1600

13217

D05AX02

ATC

calcipotriol; topical

2.1

16.5

157

762

R42

ICD-10 Finland

Dizziness and giddiness

1.4

16.5

934

7122

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

16.5

1108

8683

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.4

301

1807

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

4.8

16.3

ZXC10

NOMESCO Finland

Use of laser

2.5

16.3

102

415

H16.0

ICD-10 Finland

Corneal ulcer

1.9

16.2

216

1180

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

16.2

795

5918

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

16.1

291

1739

UKC02

NOMESCO Finland

Cystoscopy

1.5

16.0

556

3876

H93.1

ICD-10 Finland

Tinnitus

1.7

15.9

298

1799

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

15.9

128

582

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

15.9

297

1792

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

15.8

518

3571

H16.9

ICD-10 Finland

Keratitis, unspecified

2.6

15.7

333

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.3

15.7

112

483

L13

ICPC

Hip symptom/complaint

1.4

15.7

768

5708

S04

ICPC

Lump/swelling localized

1.5

15.7

439

2924

L01BA01

ATC

methotrexate; systemic

2.0

15.6

169

860

R96

ICPC

Asthma

1.6

15.6

416

2740

R03BA08

ATC

ciclesonide; inhalant

1.6

15.6

393

2555

G01AA10

ATC

clindamycin; vaginal

1.4

15.6

738

5454

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

5.3

15.6

K07.60

ICD-10 Finland

Snapping jaw

1.8

15.6

254

1475

P01AB01

ATC

metronidazole; oral, rectal

1.3

15.5

1857

15735

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

15.4

320

1986

SFA20

NOMESCO Finland

Two-surface restoration

1.3

15.3

2721

24194

N06AX21

ATC

duloxetine; oral

1.5

15.3

532

3710

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

15.3

226

1275

L04AD02

ATC

tacrolimus; systemic

3.6

15.3

141

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

15.2

384

2500

L20.8

ICD-10 Finland

Other atopic dermatitis

3.0

15.1

212

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

15.1

127

588

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

6.3

15.0

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

15.0

146

716

M48.0

ICD-10 Finland

Spinal stenosis

1.5

14.9

454

3079

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

6.5

14.9

R01AD11

ATC

triamcinolone; nasal

1.6

14.8

383

2506

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

14.8

456

3101

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

14.8

438

2954

B35.1

ICD-10 Finland

Tinea unguium

1.7

14.7

263

1567

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

14.7

2323

20327

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

14.7

254

1500

N05CF02

ATC

zolpidem; oral

1.4

14.6

770

5795

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

6.3

14.5

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.7

14.5

272

1642

SPAT1325

SPAT

Vaccination

1.3

14.5

1337

10929

C03DA01

ATC

spironolactone; oral

1.5

14.4

416

2788

M79.1

ICD-10 Finland

Myalgia

1.4

14.3

648

4746

SPAT1058

SPAT

PEF monitoring instruction

1.6

14.3

338

2165

R05

ICPC

Cough

1.3

14.2

1038

8209

K51.8

ICD-10 Finland

Other ulcerative colitis

2.7

14.2

275

D05AX03

ATC

calcitriol; topical

2.9

14.2

220

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

14.1

250

1487

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

14.1

2534

22468

J01EA01

ATC

trimethoprim; systemic

1.3

14.1

1168

9407

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

14.1

393

2616

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

14.1

1212

9812

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.2

14.0

113

515

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

14.0

374

2466

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.1

13.9

125

594

L85.3

ICD-10 Finland

Xerosis cutis

3.2

13.9

165

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.0

13.8

202

L66.1

ICD-10 Finland

Lichen planopilaris

53.5

13.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

13.8

747

5642

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.7

13.7

280

L50.0

ICD-10 Finland

Allergic urticaria

2.1

13.7

124

591

J01CA04

ATC

amoxicillin; systemic

1.3

13.7

3876

36232

L08

ICPC

Shoulder symptom/complaint

1.3

13.7

913

7120

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

13.7

1061

8459

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.0

13.6

137

680

SFA10

NOMESCO Finland

One-surface restoration

1.3

13.6

2496

22141

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

13.6

119

560

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.9

13.6

170

910

R52.9

ICD-10 Finland

Pain, unspecified

1.5

13.6

402

2710

R01AD01

ATC

beclometasone; nasal

1.4

13.6

675

5024

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

13.5

243

1451

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.5

13.5

330

L63.9

ICD-10 Finland

Alopecia areata, unspecified

5.6

13.3

S01AD03

ATC

aciclovir; ophthalmic

1.9

13.3

154

803

F02

ICPC

Red eye

1.8

13.3

184

1017

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.3

1535

12889

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.0

13.3

135

673

S01GX02

ATC

levocabastine; ophthalmic

1.7

13.2

263

1613

SCA02

NOMESCO Finland

Preventive oral health care

1.5

13.2

418

2856

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.2

1575

13273

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.9

13.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

13.2

347

2278

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

13.1

529

3791

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.2

13.1

J45

ICD-10 Finland

Asthma

1.5

13.1

446

3094

D10AD01

ATC

tretinoin; topical

2.3

13.1

439

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

13.1

353

2332

S87

ICPC

Dermatitis/atopic eczema

2.2

13.0

109

504

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

13.0

423

2906

R02

ICPC

Shortness of breath/dyspnoea

1.5

13.0

506

3602

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

12.8

980

7793

F16

ICPC

Eyelid symptom/complaint

1.7

12.7

215

1262

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

12.7

3306

30397

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

12.7

311

2008

C09CA06

ATC

candesartan; oral

1.3

12.7

985

7845

L60.0

ICD-10 Finland

Ingrowing nail

1.9

12.6

168

918

R03BA01

ATC

beclometasone; inhalant

1.4

12.6

581

4264

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

12.6

195

1116

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.4

12.6

L63.8

ICD-10 Finland

Other alopecia areata

15.4

12.6

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.5

12.6

293

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.6

1337

11098

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

12.6

2347

20791

M01AC06

ATC

meloxicam; systemic, rectal

1.3

12.5

1574

13329

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

12.5

379

2567

A01AB04

ATC

amphotericin B; local oral

1.8

12.5

176

980

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

12.5

124

614

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

2.7

12.4

237

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.3

12.4

136

D07AB01

ATC

clobetasone; topical

2.0

12.4

138

711

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.3

1838

15866

R51

ICD-10 Finland

Headache

1.7

12.3

248

1526

M04AA01

ATC

allopurinol; systemic

1.5

12.3

402

2765

K51.5

ICD-10 Finland

Left sided colitis

2.1

12.3

118

576

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

12.3

695

5277

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.3

2675

24068

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

12.3

772

5961

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

12.2

738

5661

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

12.2

298

1924

S01BA01

ATC

dexamethasone; ophthalmic

1.9

12.2

145

765

L15

ICPC

Knee symptom/complaint

1.3

12.2

990

7931

R07.0

ICD-10 Finland

Pain in throat

1.6

12.1

296

1910

KMAK, ,

NOMESCO Finland

1.2

12.1

2346

20828

S01GX09

ATC

olopatadine; ophthalmic

2.0

12.1

126

634

C10AC01

ATC

colestyramine; oral

2.1

12.1

116

567

N76.0

ICD-10 Finland

Acute vaginitis

1.6

12.0

302

1962

K50.8

ICD-10 Finland

Other Crohn disease

2.5

11.9

283

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.2

11.9

451

G50.1

ICD-10 Finland

Atypical facial pain

2.3

11.9

381

DHB00

NOMESCO Finland

Excision of lesion of external nose

3.3

11.9

130

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.7

11.9

226

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

11.8

166

923

L04AA32

ATC

apremilast; oral

5.9

11.8

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.2

11.8

447

T78.3

ICD-10 Finland

Angioneurotic oedema

2.6

11.7

256

L40.4

ICD-10 Finland

Guttate psoriasis

4.2

11.7

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.6

1242

10296

G03DB01

ATC

dydrogesterone; oral

1.4

11.6

622

4679

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

11.6

164

914

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

11.6

147

792

A02BC04

ATC

rabeprazole; oral

1.5

11.6

375

2576

SBB10

NOMESCO Finland

Dental impressions

1.6

11.5

269

1718

R13

ICD-10 Finland

Dysphagia

1.6

11.5

268

1711

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.5

1041

8450

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

11.5

553

4088

-1, ,

NOMESCO Finland

1.3

11.5

1433

12101

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

11.5

1928

16828

L56.4

ICD-10 Finland

Polymorphous light eruption

4.0

11.4

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.3

11.4

394

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.1

11.4

102

485

R01AD05

ATC

budesonide; nasal

1.5

11.4

323

2156

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

11.4

1919

16751

D01BA02

ATC

terbinafine; oral

1.3

11.4

979

7896

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.6

11.3

249

XX9XE

NOMESCO Finland

Other ultrasound examination

2.9

11.3

176

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.3

2115

18661

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

11.3

1689

14551

L84

ICD-10 Finland

Corns and callosities

1.9

11.3

134

707

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

11.3

458

3287

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

11.3

629

4765

L40.8

ICD-10 Finland

Other psoriasis

3.4

11.2

120

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.7

11.2

216

1316

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

11.2

167

947

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.7

11.2

D82

ICPC

Teeth/gum disease

1.2

11.2

1635

14048

D86.3

ICD-10 Finland

Sarcoidosis of skin

5.5

11.2

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

11.1

283

1845

R08

ICPC

Nose symptom/complaint other

1.9

11.1

145

789

S01KA02

ATC

hypromellose; ophthalmic

2.3

11.1

336

M79.7

ICD-10 Finland

Fibromyalgia

1.8

11.1

169

964

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.4

11.1

324

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

11.0

1390

11738

F01

ICPC

Eye pain

2.0

11.0

123

635

L04AB01

ATC

etanercept; parenteral

2.3

11.0

337

C05AA08

ATC

fluocortolone; rectal, topical

1.4

11.0

550

4092

R03AC03

ATC

terbutaline; inhalant

1.4

11.0

588

4424

L23

ICD-10 Finland

Allergic contact dermatitis

3.5

11.0

107

M02AA07

ATC

piroxicam; topical

1.2

10.9

1467

12478

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

10.9

200

1203

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

10.9

471

3419

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.9

10.9

164

L30

ICD-10 Finland

Other dermatitis

2.1

10.8

103

502

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.0

10.8

114

577

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

10.8

227

1414

R74

ICPC

Upper respiratory infection acute

1.2

10.8

1413

11982

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

10.8

845

6726

A07AA02

ATC

nystatin; oral

1.6

10.7

222

1377

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.7

558

4178

L29.2

ICD-10 Finland

Pruritus vulvae

2.3

10.7

367

QXA05

NOMESCO Finland

Skin division, unspecified location

4.6

10.7

J46

ICD-10 Finland

Status asthmaticus

2.0

10.7

119

615

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

10.6

363

2520

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

10.6

550

4114

S01GX04

ATC

nedocromil; ophthalmic

2.3

10.6

343

M45

ICD-10 Finland

Ankylosing spondylitis

2.2

10.5

395

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.7

10.5

200

H57.1

ICD-10 Finland

Ocular pain

1.8

10.5

160

913

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

10.5

310

2089

R09

ICPC

Sinus symptom/complaint

1.5

10.5

367

2560

R19.4

ICD-10 Finland

Change in bowel habit

2.0

10.5

116

598

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

10.4

158

900

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.1

10.4

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

3.7

10.4

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

5.4

10.4

L04AC05

ATC

ustekinumab; parenteral

4.3

10.3

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

10.3

506

3755

G01AF05

ATC

econazole; vaginal

1.5

10.3

374

2630

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.5

10.2

256

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

10.2

852

6835

R03BA05

ATC

fluticasone; inhalant

1.3

10.1

750

5918

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

10.1

693

5408

D02

ICPC

Abdominal pain epigastric

1.6

10.1

249

1612

H16.2

ICD-10 Finland

Keratoconjunctivitis

3.2

10.1

123

ZZR00

NOMESCO Finland

Flap of skin

2.3

10.1

344

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

10.1

227

1438

R03AC13

ATC

formoterol; inhalant

1.7

10.1

202

1243

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

10.1

962

7846

D06BB03

ATC

aciclovir; topical

1.7

10.1

200

1228

K90.0

ICD-10 Finland

Coeliac disease

1.9

10.1

119

627

UDC00

NOMESCO Finland

Ear microscopy

1.5

10.1

283

1888

H13

ICPC

Plugged feeling ear

1.3

10.0

699

5469

S82

ICPC

Naevus/mole

1.4

10.0

546

4118

R21

ICPC

Throat symptom/complaint

1.3

10.0

888

7178

A07EA02

ATC

hydrocortisone; rectal

2.1

10.0

437

L72.0

ICD-10 Finland

Epidermal cyst

3.2

10.0

124

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

10.0

333

2302

L28.1

ICD-10 Finland

Prurigo nodularis

3.3

10.0

114

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

10.0

313

2137

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.7

9.9

193

1179

C03CA01

ATC

furosemide; systemic

1.3

9.9

956

7806

M34.1

ICD-10 Finland

CR(E)ST syndrome

3.8

9.9

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

9.9

1030

8488

ZX120

NOMESCO Finland

Intravenous

1.5

9.9

353

2472

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

9.9

889

7197

A03FA02

ATC

cisapride; oral, rectal

1.5

9.9

269

1782

XQ899

NOMESCO Finland

Other assessment of skin

3.9

9.8

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.2

9.8

115

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

9.8

181

1091

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

9.8

307

2095

DLW99

NOMESCO Finland

Other plastic operations on nose

20.1

9.8

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

9.8

488

D01AC02

ATC

miconazole; topical

1.5

9.7

268

1779

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

9.7

146

830

N06AA09

ATC

amitriptyline; systemic

1.4

9.7

374

2656

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

9.7

150

860

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.9

9.7

119

635

C08CA01

ATC

amlodipine; oral

1.2

9.7

1401

11978

WX002

NOMESCO Finland

Sedation and analgesia

1.3

9.7

745

5905

XQ801

NOMESCO Finland

Intracutantest

3.3

9.7

106

D11AX14

ATC

[U] tacrolimus

3.7

9.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

9.7

460

3393

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

9.6

393

2821

R06AX18

ATC

acrivastine; oral

1.9

9.6

119

637

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.8

9.6

153

885

H01

ICPC

Ear pain/earache

1.4

9.6

471

3490

XPX04

NOMESCO Finland

Angioscopy

4.2

9.6

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.6

9.6

210

M77.4

ICD-10 Finland

Metatarsalgia

1.5

9.6

259

1712

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

9.6

982

8074

D01AA02

ATC

natamycin; topical

2.1

9.6

398

C07AB07

ATC

bisoprolol; oral

1.2

9.6

1841

16206

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

9.6

432

3158

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

9.6

304

2081

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

9.6

1174

9860

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

9.5

327

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

9.5

824

6634

M01AH01

ATC

celecoxib; oral

1.3

9.5

707

5578

ZQX00

NOMESCO Finland

0-4% of the skin

10.0

9.5

J01MA14

ATC

moxifloxacin; systemic

1.5

9.5

332

2316

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

9.5

295

2010

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

4.0

9.5

H10

ICD-10 Finland

Conjunctivitis

1.5

9.5

303

2076

L12

ICPC

Hand/finger symptom/complaint

1.3

9.5

650

5072

N04BC05

ATC

pramipexole; oral

1.5

9.4

290

1971

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

9.4

276

1857

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.9

9.4

119

642

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

9.4

240

1567

QAA30

NOMESCO Finland

Electrocoagulation of skin of head or neck

30.1

9.4

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

3.9

9.4

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

9.4

147

847

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.5

9.4

318

2206

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.3

991

8181

L81.7

ICD-10 Finland

Pigmented purpuric dermatosis

4.4

9.3

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.3

333

2334

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

9.3

623

4847

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

9.2

574

4414

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

9.2

444

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

9.2

250

1655

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

9.2

288

1965

E000008, ,

ATC

7.3

9.2

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.7

9.2

186

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.2

9.2

346

M01CB01

ATC

sodium aurothiomalate; parenteral

2.5

9.1

234

S02

ICPC

Pruritus

1.8

9.1

134

759

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

9.1

215

1381

L04AA13

ATC

[U] leflunomide

1.9

9.1

108

572

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

9.1

181

1115

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

9.0

468

H29

ICPC

Ear symptom/complaint other

1.4

9.0

430

3171

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

9.0

207

1319

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.3

9.0

272

P06

ICPC

Sleep disturbance

1.4

9.0

473

3546

K58

ICD-10 Finland

Irritable bowel syndrome

1.9

9.0

108

574

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.6

9.0

194

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

8.9

428

3160

SAA04

NOMESCO Finland

Special examination of mouth

1.6

8.9

203

1291

A11CC03

ATC

alfacalcidol; systemic

2.1

8.9

396

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.5

8.9

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

8.9

141

816

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

8.9

719

5736

S15

ICPC

Foreign body in skin

1.5

8.9

237

1564

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.3

8.9

102

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.0

8.9

451

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.8

485

3661

H92.0

ICD-10 Finland

Otalgia

1.5

8.8

248

1656

L64.9

ICD-10 Finland

Androgenic alopecia, unspecified

8.6

8.8

A46

ICD-10 Finland

Erysipelas

1.4

8.8

486

3674

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.8

8.8

120

665

D09AB01

ATC

zinc bandage without supplements; topical

2.2

8.8

346

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.7

1520

13222

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

8.7

182

1134

F72

ICPC

Blepharitis/stye/chalazion

2.0

8.7

468

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

3.9

8.7

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

8.7

181

1128

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

3.6

8.7

N06AX16

ATC

venlafaxine; oral

1.3

8.6

608

4760

N39.3

ICD-10 Finland

Stress incontinence

1.4

8.6

317

2234

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

8.6

145

855

L18

ICPC

Muscle pain

1.7

8.5

154

925

N05CF01

ATC

zopiclone; oral

1.2

8.5

1266

10838

H02.1

ICD-10 Finland

Ectropion of eyelid

3.3

8.5

K03.00

ICD-10 Finland

Approximal wear

1.5

8.4

276

1901

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

8.4

432

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.2

8.4

293

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

8.4

345

2480

R04.0

ICD-10 Finland

Epistaxis

1.5

8.4

245

1648

ZQZ00

NOMESCO Finland

Treatment of several skin areas

3.9

8.4

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.9

8.4

R50.9

ICD-10 Finland

Fever, unspecified

1.3

8.4

554

4297

M01AH02

ATC

rofecoxib; oral

1.4

8.4

459

3462

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

8.4

526

4051

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

8.4

1008

8434

ZXA10

NOMESCO Finland

Bilateral

1.3

8.3

682

5447

D75.2

ICD-10 Finland

Essential thrombocytosis

3.3

8.3

R03AC12

ATC

salmeterol; inhalant

1.7

8.3

153

923

UJD02

NOMESCO Finland

Gastroscopy

1.6

8.3

171

1063

XCK00

NOMESCO Finland

Perimetry

1.5

8.3

217

1427

A92

ICPC

Allergy/allergic reaction NOS

1.8

8.3

118

663

K08.80

ICD-10 Finland

Toothache NOS

1.4

8.3

363

2642

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.9

8.3

105

569

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

8.2

246

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

8.2

798

6514

S96

ICPC

Acne

2.8

8.1

140

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

8.1

631

5004

B35.3

ICD-10 Finland

Tinea pedis

1.6

8.1

164

1014

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

8.1

547

4255

SPAT1216

SPAT

Assessment of functional ability

1.3

8.1

527

4080

N05BA01

ATC

diazepam; systemic, rectal

1.3

8.1

481

3676

-, ,

ICD-10 Finland

2.0

8.1

412

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

8.1

225

1501

D11AH05

ATC

dupilumab; topical

6.8

8.0

D01

ICPC

Abdominal pain/cramps general

1.3

8.0

464

3529

S01AA02

ATC

chlortetracycline; ophthalmic

3.0

8.0

114

L01XX35

ATC

anagrelide; oral

10.0

8.0

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

8.0

152

925

ZXC20

NOMESCO Finland

Use of chemical agents

2.2

8.0

306

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.0

8.0

441

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.4

8.0

206

395

Kela drug reimbursment

Dupilumab

7.2

7.9

A06AD11

ATC

lactulose; oral

1.3

7.9

474

3624

B35.8

ICD-10 Finland

Other dermatophytoses

4.3

7.9

M02AA10

ATC

ketoprofen; topical

1.3

7.9

622

4940

G04CA02

ATC

tamsulosin; oral

1.3

7.9

598

4725

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

7.9

430

3240

U02

ICPC

Urinary frequency/urgency

1.3

7.9

565

4431

HMAK, ,

NOMESCO Finland

1.3

7.9

471

3600

SPAT1229

SPAT

Assessment of need for aid

1.5

7.9

260

1795

G54.0

ICD-10 Finland

Brachial plexus disorders

1.8

7.9

109

607

C08CA13

ATC

lercanidipine; oral

1.3

7.9

494

3804

L68.0

ICD-10 Finland

Hirsutism

7.7

7.9

L14

ICPC

Leg/thigh symptom/complaint

1.4

7.8

289

2038

R03BC03

ATC

nedocromil; inhalant

1.5

7.8

264

1830

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.6

7.8

A12AA04

ATC

calcium carbonate; oral

2.4

7.8

226

L43.3

ICD-10 Finland

Subacute (active) lichen planus

6.1

7.8

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

7.8

1162

9932

H00

ICD-10 Finland

Hordeolum and chalazion

2.5

7.8

184

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

7.8

431

D06BB04

ATC

podophyllotoxin; topical

1.6

7.8

198

1294

L04AA17

ATC

[U] adalimumab

4.1

7.8

C02AC05

ATC

moxonidine; oral

1.7

7.8

150

917

H26.3

ICD-10 Finland

Drug-induced cataract

3.2

7.8

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

6.9

7.8

XKD00

NOMESCO Finland

Uroflowmetry

1.4

7.7

433

3279

A06AC51

ATC

ispaghula, combinations; oral

1.6

7.7

179

1146

S76

ICPC

Skin infection other

1.6

7.7

185

1194

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

7.7

455

3474

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

5.9

7.7

D19

ICPC

Teeth/gum symptom/complaint

1.2

7.6

1182

10138

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

7.6

415

3127

F13

ICPC

Eye sensation abnormal

1.8

7.6

106

591

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

7.6

191

1245

SPAT1053

SPAT

Memory test

1.4

7.6

412

3104

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

2.7

7.6

140

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.0

7.6

360

JG1JB

NOMESCO Finland

Defekography with X-ray

2.6

7.5

152

WZC30

NOMESCO Finland

Teaching

1.3

7.5

598

4756

N06AX26

ATC

vortioxetine; oral

1.4

7.5

278

1962

H60.8

ICD-10 Finland

Other otitis externa

1.8

7.5

116

668

A05AA02

ATC

ursodeoxycholic acid; oral

2.1

7.5

348

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.2

7.5

269

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.1

7.5

302

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

7.4

121

707

R00.2

ICD-10 Finland

Palpitations

1.4

7.4

309

2228

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.0

7.4

404

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.7

7.4

119

693

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.8

7.4

101

561

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.9

7.4

109

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

7.4

183

1191

H02.3

ICD-10 Finland

Blepharochalasis

1.5

7.3

235

1614

EB4VA, ,

NOMESCO Finland

1.3

7.3

445

3410

S88

ICPC

Dermatitis contact/allergic

2.0

7.3

399

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.8

7.3

548

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

7.3

123

726

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

+∞

7.3

R12

ICD-10 Finland

Heartburn

1.4

7.3

303

2186

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.1

7.2

319

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

7.2

319

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

7.2

241

1668

M03AX01

ATC

botulinum toxin; parenteral

2.2

7.2

273

D18.0

ICD-10 Finland

Haemangioma, any site

1.8

7.2

543

M35.1

ICD-10 Finland

Other overlap syndromes

3.3

7.2

L64.8

ICD-10 Finland

Other androgenic alopecia

15.8

7.2

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

2.7

7.2

144

B02.9

ICD-10 Finland

Zoster without complication

1.5

7.2

234

1612

G01AF01

ATC

metronidazole; vaginal

1.3

7.2

413

3139

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

7.2

978

8276

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

7.2

332

2439

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

7.1

282

2015

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

3.9

7.1

TK800

NOMESCO Finland

Hemodialysis

2.1

7.1

314

A05

ICPC

Feeling ill

1.5

7.1

221

1508

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

7.1

149

931

S91

ICPC

Psoriasis

2.6

7.1

145

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

7.1

190

1257

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

6.6

7.1

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.1

2302

21050

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.4

7.1

187

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

4.1

7.1

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.3

7.0

212

C07AG02

ATC

carvedilol; oral

1.5

7.0

181

1188

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

7.0

133

811

SPAT1360

SPAT

Extensive global examination

1.5

7.0

244

1704

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

7.0

385

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.9

7.0

420

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

7.0

222

1523

L85.81

ICD-10 Finland

Keratosis pilaris

7.0

L43.0

ICD-10 Finland

Hypertrophic lichen planus

3.2

7.0

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.1

7.0

324

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.6

7.0

161

1031

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

7.0

322

2366

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

2.3

6.9

226

J01DC02

ATC

cefuroxime; systemic

1.5

6.9

218

1492

137

Kela drug reimbursment

Uraemia requiring dialysis

2.8

6.9

113

I78.8

ICD-10 Finland

Other diseases of capillaries

6.3

6.9

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.4

6.9

177

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.9

200

1347

C05AA01

ATC

hydrocortisone; rectal, topical

1.5

6.9

187

1242

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

6.9

306

2234

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

2.6

6.9

142

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

6.9

233

1620

N64.4

ICD-10 Finland

Mastodynia

1.6

6.8

134

824

ZXA00

NOMESCO Finland

Right side

1.2

6.8

973

8268

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.8

659

5368

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

6.8

438

ZX108

NOMESCO Finland

Inhalation

3.0

6.8

A01

ICPC

Pain general/multiple sites

1.4

6.8

337

2506

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.2

6.8

248

G03CA04

ATC

estriol; systemic, vaginal

1.5

6.7

200

1354

L04

ICPC

Chest symptom/complaint

1.5

6.7

225

1560

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

6.7

371

2804

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

6.7

319

2355

3005

Kela drug reimbursment

Tofacitinib

3.9

6.7

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.2

6.6

237

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

6.6

121

731

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

2.8

6.6

116

J01CA08

ATC

pivmecillinam; oral

1.2

6.6

1895

17123

H16.8

ICD-10 Finland

Other keratitis

4.0

6.6

L50

ICD-10 Finland

Urticaria

1.9

6.6

372

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

5.9

6.6

J01DA06

ATC

[U] cefuroxime

1.3

6.6

551

4410

R68.8

ICD-10 Finland

Other specified general symptoms and signs

2.7

6.6

122

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.1

6.6

264

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

3.6

6.6

J45.8

ICD-10 Finland

Mixed asthma

1.7

6.6

115

687

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

6.6

220

1526

C08CA05

ATC

nifedipine; systemic

1.5

6.6

191

1288

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

6.6

151

967

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.6

6.5

134

UJH02

NOMESCO Finland

Anoscopy

1.6

6.5

151

968

K13.03

ICD-10 Finland

Keilit UNS

3.8

6.5

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.7

6.5

114

681

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

6.5

353

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.1

6.5

285

SBA00

NOMESCO Finland

Microbiological examinations

1.8

6.5

532

L04AC16

ATC

guselkumab; systemic

6.8

6.5

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

6.5

223

1554

D07XB02

ATC

triamcinolone; topical

2.2

6.5

246

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.8

6.5

555

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

6.5

314

2326

UDM02

NOMESCO Finland

Sinoscopy

1.8

6.5

453

D07CB01

ATC

triamcinolone and antibiotics; topical

1.9

6.5

368

S19

ICPC

Skin injury other

1.6

6.5

129

798

L04AC18

ATC

risankizumab; parenteral

6.2

6.5

QDH00

NOMESCO Finland

Avulsion of toe nail

6.2

6.5

QAA10

NOMESCO Finland

Incision of skin of head or neck

6.2

6.5

X58

ICD-10 Finland

Exposure to other specified factors

1.3

6.4

513

4080

J02AB02

ATC

ketoconazole; oral

1.7

6.4

110

653

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.0

6.4

327

M54.2

ICD-10 Finland

Cervicalgia

1.4

6.4

311

2302

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.6

6.4

141

D02BB01

ATC

betacarotene; oral

3.9

6.4

L81.1

ICD-10 Finland

Chloasma

3.5

6.4

SPAT1009

SPAT

Measurement of intraocular pressure

2.2

6.4

234

ZZA00

NOMESCO Finland

Split skin graft

1.8

6.4

476

130

Kela drug reimbursment

Malignant tumour

0.6

6.4

125

1977

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.1

6.4

267

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

6.4

144

917

S01AA13

ATC

fusidic acid; ophthalmic

1.7

6.4

106

625

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

6.4

228

1602

G03DC02

ATC

norethisterone; oral

1.3

6.4

442

3453

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.1

6.4

248

L01

ICD-10 Finland

Impetigo

2.1

6.4

248

L08.0

ICD-10 Finland

Pyoderma

2.6

6.4

136

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

2.6

6.4

136

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

6.3

353

2672

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

6.3

136

857

H02

ICPC

Hearing complaint

1.3

6.3

453

3554

M23.8

ICD-10 Finland

Other internal derangements of knee

1.6

6.3

140

889

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

3.6

6.3

L04AC10

ATC

secukinumab; parenteral

3.1

6.3

N05BB01

ATC

hydroxyzine; systemic

1.4

6.3

221

1548

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

6.3

245

1750

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.6

6.3

133

836

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.4

6.2

329

2470

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

6.2

138

876

J01FA15

ATC

telithromycin; oral

1.3

6.2

390

3003

R06.2

ICD-10 Finland

Wheezing

1.5

6.2

156

1020

TGC00

NOMESCO Finland

Bronchial lavation

1.8

6.2

445

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.2

1012

8706

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

2.9

6.2

K59.0

ICD-10 Finland

Constipation

1.5

6.2

184

1247

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

6.2

230

1628

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

6.2

347

2630

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

6.2

244

1746

SFA30

NOMESCO Finland

Three-surface restoration

1.2

6.2

1780

16069

D11AX15

ATC

[U] pimecrolimus

5.0

6.2

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

6.2

780

6544

L53.8

ICD-10 Finland

Other specified erythematous conditions

4.0

6.2

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

6.1

1088

9429

B05DA

ATC

Isotonic solutions

2.9

6.1

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

6.1

244

1748

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

5.7

6.1

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

6.1

189

1291

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

6.1

366

2801

K13.00

ICD-10 Finland

Cheilitis NOS

2.7

6.1

110

Z00.8

ICD-10 Finland

Other general examinations

1.4

6.1

273

1997

M01AX01

ATC

nabumetone; oral

1.6

6.1

145

937

SPAT1254

SPAT

Administration of medicine

1.3

6.1

496

3960

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.6

6.0

124

773

L65.8

ICD-10 Finland

Other specified nonscarring hair loss

8.6

6.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.0

333

2517

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.9

6.0

370

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

6.0

212

1485

L04AA29

ATC

[U] tofacitinib

3.6

6.0

N06AB10

ATC

escitalopram; oral

1.2

6.0

844

7154

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

1226

5970

2.40

138.62

1.6

1.4

618.23

571.79

titre

0.31

294

1282

(40768443) Skin Pathology biopsy report

510

1748

3.14

113.77

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2754

19588

1.90

104.81

8.8

6.2

—

(3006315) Basophils [#/volume] in Blood

2881

20865

1.90

102.89

7.9

5.7

0.04

e9/l

0.32

2602

18076

(3001604) Monocytes [#/volume] in Blood

2875

20818

1.90

102.61

7.9

5.7

0.54

0.56

e9/l

7.09

2600

18061

(3013115) Eosinophils [#/volume] in Blood

2946

21603

1.89

99.93

8.2

5.9

0.18

0.19

e9/l

2.39

2678

19044

(3015171) Extractable nuclear Ab [Units/volume] in Serum

489

1766

2.96

99.08

1.4

1.3

1.36

1.05

u/ml

0.22

160

(3019198) Lymphocytes [#/volume] in Blood

2919

21456

1.87

97.00

7.9

5.8

1.88

1.94

e9/l

0.80

2669

19069

(3013707) Erythrocyte sedimentation rate by Westergren method

3873

31298

2.05

95.90

5.5

4.0

11.48

11.67

mm/h

0.39

3642

29127

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

402

1330

3.20

94.71

2.2

1.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

395

1325

3.15

90.83

2.2

1.7

1.16

1.19

g/l

0.83

379

1250

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

384

1279

3.17

89.34

2.2

1.8

0.22

0.23

g/l

1.90

364

1207

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

367

1244

3.10

82.74

1.4

1.3

36.87

40.27

u/ml

0.09

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3843

31781

1.90

77.77

8.9

7.3

75.60

76.76

u/l

1.02

3653

30012

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

337

1137

3.11

76.48

1.4

1.3

12.17

9.00

u/ml

0.27

190

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

334

1122

3.12

76.36

1.4

1.3

11.53

5.93

u/ml

0.47

116

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

293

913

3.35

75.85

1.4

1.3

4.70

2.98

u/ml

0.31

(3013650) Neutrophils [#/volume] in Blood by Automated count

3097

24148

1.74

74.76

10.3

8.9

3.87

4.01

e9/l

2.70

2817

21109

(3006504) Eosinophils/100 leukocytes in Blood

2614

19521

1.71

73.18

8.2

5.9

2.80

2.84

0.51

2481

18248

(3019069) Monocytes/100 leukocytes in Blood

2625

19627

1.71

73.14

8.5

6.2

8.35

8.40

0.39

2498

18392

(3005322) IgE [Units/volume] in Serum or Plasma

597

2790

2.29

70.20

1.4

1.3

192.19

184.68

u/ml

0.10

568

2578

(3018010) Neutrophils/100 leukocytes in Blood

2640

19936

1.69

69.41

7.8

5.8

57.01

56.85

0.31

2509

18699

(3002030) Lymphocytes/100 leukocytes in Blood

2665

20209

1.68

68.67

8.3

6.0

28.61

28.53

0.16

2535

18977

(3022096) Basophils/100 leukocytes in Blood

2524

18888

1.68

68.24

8.3

6.0

0.72

0.69

2.45

2386

17605

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2362

17706

1.63

60.80

2.7

2.2

78.16

77.05

nmol/l

1.07

2182

16110

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1238

7861

1.76

59.57

1.4

1.3

34.37

32.33

iu/ml

0.14

388

2565

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1461

9871

1.68

55.38

1.4

1.3

1.48

1.58

u/ml

0.14

412

2738

(3007853) Bacteria identified in Skin by Aerobe culture

812

4635

1.90

54.87

1.9

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

266

949

2.90

54.45

1.3

44.80

41.54

u/ml

0.13

103

(3048689) Calprotectin [Mass/mass] in Stool

902

5365

1.83

53.37

2.8

2.3

111.30

122.46

ug/g

0.52

717

4242

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1166

7537

1.71

51.54

1.3

7.41

11.52

u/ml

1.66

475

3050

(3037467) Urinalysis macro (dipstick) panel - Urine

3433

28801

1.61

50.95

5.1

4.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1279

8563

1.66

49.16

1.6

1.4

2.48

2.33

g/l

1.83

831

5301

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3887

33817

1.67

47.95

4.8

4.2

14.69

14.64

pmol/l

0.56

3582

31106

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4606

42203

2.16

47.52

16.2

12.9

18.84

22.19

mg/l

10.60

3737

33157

(3026493) Urate [Moles/volume] in Serum or Plasma

1473

10366

1.60

45.66

3.0

2.5

3834.57

4205.21

umol/l

0.14

1286

9173

(3029937) Albumin [Presence] in Urine by Test strip

1534

10936

1.58

44.82

5.0

3.9

0.00

estimate

1.94

535

3784

(3039162) Centromere protein B Ab [Units/volume] in Serum

175

555

3.23

43.90

1.3

74.58

56.55

u/ml

—

(3000494) Fungus identified in Specimen by Culture

791

4791

1.77

43.21

1.6

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4368

39559

1.83

42.86

5.7

4.9

1.87

2.07

mu/l

1.38

4072

36661

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2480

19759

1.51

42.81

7.4

6.4

1.22

mmol/l

0.34

2126

16739

(3005719) IgG [Mass/volume] in Serum or Plasma

573

3159

1.92

42.32

3.2

2.7

10.71

10.52

g/l

0.49

529

2890

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2276

17901

1.50

41.28

6.6

5.7

1.22

1.21

mmol/l

0.63

2091

16356

(3021601) Nitrite [Presence] in Urine by Test strip

2554

20571

1.49

41.16

5.8

4.7

0.00

estimate

0.80

554

3874

(40768804) Tissue Pathology biopsy report

2264

17797

1.50

41.11

2.4

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

2571

20780

1.49

40.42

4.5

3.5

0.00

estimate

0.06

529

3809

(3035350) Ketones [Presence] in Urine by Test strip

2540

20561

1.48

39.09

4.5

3.5

0.00

estimate

1.94

566

4078

(3004616) Nuclear Ab [Presence] in Serum

160

526

3.11

37.81

1.5

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3228

27564

1.48

36.77

5.0

4.2

2178.56

1757.99

e6/l

0.15

344

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4768

44929

2.33

35.42

13.6

9.9

25.92

25.51

u/l

0.67

4652

43457

(3024561) Albumin [Mass/volume] in Serum or Plasma

2154

17102

1.46

35.29

5.7

4.7

36.21

35.83

g/l

2.81

2016

15939

(3015736) pH of Urine

2096

16559

1.46

35.23

4.1

3.2

5.89

0.03

150

1381

(3021589) Normoblasts [#/volume] in Blood

2302

18529

1.45

34.96

11.6

9.1

0.00

e9/l

1.03

1965

15114

(3022145) Colonoscopy Study observation

729

4573

1.70

34.52

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

452

2460

1.92

34.43

2.0

1.8

1.35

1.37

g/l

0.06

415

2262

(3038026) Centromere Ab [Units/volume] in Serum

115

335

3.49

33.07

1.3

1.2

41.25

62.10

u/ml

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2559

21136

1.43

33.05

6.0

10.93

10.74

umol/l

0.36

2418

20031

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

111

325

3.47

31.68

1.3

1.2

69.54

35.76

u/ml

0.70

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1997

15863

1.43

31.46

4.7

3.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1654

12706

1.45

31.17

3.0

2.5

57.24

65.01

u/l

0.65

1517

11728

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2359

19350

1.41

30.80

3.3

2.8

118.12

106.84

ug/l

0.75

2214

18047

(3025159) Blasts/100 leukocytes in Blood

525

3115

1.77

30.13

5.4

4.1

0.22

0.40

0.45

133

794

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2015

16137

1.42

29.84

2.0

1.9

98.64

96.58

pmol/l

1.03

1048

8254

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4386

40564

1.66

29.81

4.8

4.3

5.80

5.84

mmol/l

1.21

4079

37342

(3022948) Iron [Moles/volume] in Serum or Plasma

899

6142

1.57

29.74

2.7

2.4

13.85

13.46

umol/l

0.87

838

5749

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

104

308

3.43

29.18

1.3

1.2

11.44

6.30

u/ml

—

(3021440) Promyelocytes/100 leukocytes in Blood

540

3260

1.74

29.12

5.5

4.1

0.12

0.11

0.03

146

935

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1347

10093

1.46

28.39

2.4

2.2

2.99

2.87

mg/l

0.73

1174

8659

(3018418) pH of Serum or Plasma

1537

11807

1.44

28.34

4.6

3.9

7.40

0.88

300

2305

(3017181) Myelocytes/100 leukocytes in Blood

557

3417

1.71

28.31

5.4

4.1

0.96

0.91

0.13

162

1093

(3019420) Tryptase [Mass/volume] in Serum or Plasma

221

3.85

28.09

1.3

1.5

5.52

8.63

ug/l

1.98

192

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1547

11917

1.43

28.03

2.4

2.1

146.22

195.60

u/l

2.55

1448

11202

(3002179) Metamyelocytes/100 leukocytes in Blood

517

3132

1.73

27.47

5.2

3.9

0.71

0.69

0.04

146

956

(3036481) Cortisol [Moles/volume] in Serum or Plasma

619

3943

1.65

27.22

2.3

2.2

353.90

373.39

nmol/l

1.25

560

3642

(40761511) CBC panel - Blood by Automated count

4678

44236

1.90

27.03

15.0

12.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4574

42977

1.76

26.81

17.5

14.4

3.94

3.95

mmol/l

0.55

4463

41830

(3019550) Sodium [Moles/volume] in Serum or Plasma

4562

42843

1.74

26.65

17.3

14.3

139.55

139.69

mmol/l

3.77

4461

41783

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

332

1778

1.93

26.40

2.1

1.9

39.97

39.60

u/l

0.12

300

1600

(3009542) Hematocrit [Volume Fraction] of Blood

4890

47082

2.77

26.15

24.5

19.2

40.20

40.21

0.02

4618

44401

(3009445) Proteinase 3 Ab [Units/volume] in Serum

309

1629

1.96

25.73

1.9

1.5

19.11

14.89

u/ml

0.16

(3010813) Leukocytes [#/volume] in Blood

4893

47153

2.78

25.59

24.4

19.1

6.59

6.65

e9/l

0.80

4809

45937

(3000963) Hemoglobin [Mass/volume] in Blood

4894

47173

2.78

25.48

24.5

19.2

134.75

134.49

g/l

0.72

4851

46579

(40768797) Stomach Pathology biopsy report

832

5770

1.53

25.33

1.3

1.2

—

(3024731) MCV [Entitic volume]

4892

47153

2.75

25.31

24.3

19.1

91.19

90.85

5.81

4846

46564

(3026361) Erythrocytes [#/volume] in Blood

4892

47160

2.74

25.17

24.4

19.1

4.47

e12/l

0.38

4809

45950

(3035941) MCH [Entitic mass]

4891

47152

2.73

25.04

24.3

19.0

30.34

30.23

4.69

4846

46560

(3007461) Platelets [#/volume] in Blood

4889

47130

2.70

24.91

24.4

19.1

257.48

257.56

e9/l

0.03

4818

46029

(3019309) Folate [Moles/volume] in Red Blood Cells

967

6949

1.49

24.75

1.7

1188.28

1172.43

nmol/l

0.21

740

5324

(40761535) Cells panel - Urine sediment

515

3214

1.67

24.40

4.5

3.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

262

1332

2.02

24.19

1.7

1.6

0.99

5.32

iu/ml

0.46

268

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4451

41701

1.61

24.13

5.0

4.2

4.70

4.77

mmol/l

5.29

4210

39006

(3017143) Hepatitis C virus Ab [Presence] in Serum

732

5004

1.54

23.67

1.7

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4501

42356

1.63

23.09

5.3

4.6

2.78

2.83

mmol/l

3.97

4219

39392

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

185

837

2.26

23.08

4.4

3.6

54.29

57.11

2.21

185

837

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

751

5218

1.52

22.43

2.9

2.5

23.74

23.14

0.57

631

4491

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

223

1101

2.07

22.31

2.2

2.0

10.80

11.13

mg/l

0.22

211

1015

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

252

1301

1.99

22.29

1.7

1.6

295.42

384.33

titre

0.15

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1787

14530

1.36

22.14

3.6

3.3

60.82

83.04

ng/l

0.18

1135

9062

(3011397) Hemoglobin [Presence] in Urine by Test strip

1253

9620

1.40

22.10

4.7

3.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

798

5634

1.50

22.04

2.8

2.4

2.38

2.37

g/l

0.40

740

5237

(3025941) Bacteria identified in Stool by Culture

412

2488

1.71

22.01

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1163

8828

1.41

21.86

5.0

3.8

1.02

kg/l

0.88

145

1333

(4200892) Spirometry reversibility

460

2880

1.66

21.44

1.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4105

38012

1.45

21.34

5.9

5.3

38.55

39.16

mmol/mol

5.32

3838

35393

(3000850) Epithelial cells [#/volume] in Urine

1098

8294

1.42

21.12

3.0

2.5

6.30

6.53

e6/l

0.11

996

7429

(3018095) Leukocytes [#/volume] in Urine

1740

14187

1.35

20.83

4.4

3.5

87.20

103.51

e6/l

0.29

1272

9838

(3023420) DNA double strand Ab [Units/volume] in Serum

122

481

2.57

20.67

2.2

1.5

27.15

23.15

iu/ml

0.19

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1125

8567

1.40

20.58

1.7

1.6

50372382.02

35005977.30

pmol/l

0.25

941

7216

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

197

3.54

20.57

1.1

—

(36660697) Celiac disease serology panel - Serum

531

3482

1.59

20.47

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4406

41449

1.53

20.43

4.8

4.1

1.51

mmol/l

0.18

4127

38583

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1379

10895

1.37

20.09

1.9

1.6

1.36

1.37

mmol/l

0.17

1175

9199

(3044889) 12 lead EKG panel

3212

28699

1.33

19.99

4.0

3.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1287

10074

1.37

19.83

3.0

2.9

1120.13

1207.63

ng/l

0.29

1080

8567

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4269

39966

1.47

19.62

4.5

3.7

1.27

mmol/l

0.08

4002

36940

(3003327) Ova and parasites identified in Stool by Light microscopy

261

1425

1.88

19.55

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

608

4156

1.53

19.43

4.7

4.2

245.39

243.36

u/l

0.11

574

3929

(3013826) Glucose [Moles/volume] in Serum or Plasma

2688

23495

1.31

19.14

5.4

4.4

6.49

6.60

mmol/l

2.24

2538

21842

(3021960) Folate [Moles/volume] in Serum or Plasma

1152

8919

1.38

18.84

1.6

1.5

20.30

20.72

nmol/l

0.39

994

7687

(3026389) Candida sp identified in Specimen by Organism specific culture

142

629

2.29

18.68

1.4

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4245

39800

1.44

18.38

14.5

11.8

83.05

83.47

ml/min/173m2

0.64

3582

32845

(3004588) Protein electrophoresis panel - Serum or Plasma

397

2493

1.64

18.22

2.2

2.3

—

(36304419) Bacteria [Presence] in Urine

1342

10699

1.35

18.08

3.6

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

343

2084

1.69

17.87

1.2

1.1

21.67

157.39

titre

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

433

2794

1.60

17.79

1.9

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1672

13816

1.32

17.44

3.2

3.3

2.35

mmol/l

2.09

1480

12299

(40758558) Short blood count panel - Blood

1323

10579

1.34

17.34

8.0

6.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

768

2.12

17.30

8.1

5.1

252.46

537.42

iu/ml

0.81

105

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

154

729

2.15

17.26

1.2

—

237.14

—

(3020630) Protein [Mass/volume] in Serum or Plasma

461

3041

1.57

17.23

2.3

2.5

67.24

66.71

g/l

0.81

423

2788

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1098

8550

1.36

17.08

1.6

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1357

10914

1.33

17.04

3.7

3.0

0.29

0.39

e6/l

1.59

1065

8250

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

106

434

2.47

16.67

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

679

4896

1.45

16.49

7.7

5.6

1.04

mmol/l

0.11

643

4555

(3002385) Erythrocyte distribution width [Ratio]

3956

36822

1.36

16.41

19.1

15.4

14.87

14.77

0.49

3897

36207

(3002582) Erythrocytes [#/volume] in Urine

1453

11854

1.32

16.38

3.8

3.1

29.72

84.75

e6/l

3.49

1149

9043

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1187

9407

1.34

16.36

1.8

1.7

0.95

1.09

mg/l

1.45

875

7170

(3022217) INR in Platelet poor plasma by Coagulation assay

2057

17580

1.29

16.35

14.4

13.1

1.22

1.21

inr

0.13

676

5255

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3166

28642

1.29

15.72

3.5

3.0

48.68

43.88

u/l

1.50

2942

26857

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1661

13891

1.29

15.35

3.7

3.1

31.80

33.60

u/l

0.55

1574

13229

(3013139) Helicobacter pylori Ag [Presence] in Stool

441

2957

1.54

15.28

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

164

836

1.99

15.11

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1375

11264

1.30

14.73

3.7

3.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

476

3280

1.50

14.49

1.2

95.75

157.09

iu/ml

4.08

206

1241

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

150

755

2.02

14.34

1.6

1.4

108.63

115.49

u/ml

0.33

161

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

150

3.36

13.93

1.2

0.28

0.30

g/l

0.70

124

(3024980) IgG subclass 4 [Mass/volume] in Serum

139

689

2.05

13.87

1.4

1.6

0.65

0.74

g/l

0.54

110

517

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

108

489

2.24

13.59

1.1

—

2.89

—

(3023520) Reticulocytes [#/volume] in Blood

435

2982

1.50

13.57

2.7

2.6

68.98

70.56

e9/l

0.40

315

2231

(46235355) HIV 1 and 2 tests - Meaningful Use set

1037

8257

1.32

13.47

1.9

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

562

4056

1.43

13.45

2.7

2.6

1.74

1.77

0.34

509

3608

(3010375) cycloSPORINE [Mass/volume] in Blood

164

3.19

13.38

21.5

25.8

114.46

113.54

ug/l

0.03

137

(44813793) Dust mix specific IgE antibody measurement

314

2.54

13.30

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

116

3.64

13.26

2.2

2.0

9.33

10.46

mg/l

0.61

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

160

847

1.92

13.26

1.6

1.3

—

18.18

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

429

2947

1.50

13.24

4.7

3.6

88.21

85.28

ng/l

0.29

378

2544

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3157

28862

1.25

12.83

3.3

3.1

—

(4062490) Immunoglobulin typing, IgG

440

2.25

12.62

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

461

3248

1.46

12.52

1.5

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

3.85

12.33

1.9

1.7

50.16

143.06

au/ml

—

(3042936) Bacteria identified in Isolate by Culture

722

5516

1.36

12.29

2.1

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

142

3.26

12.28

3.1

2.8

8.76

7.82

mg/l

0.43

111

(3048929) Epstein Barr virus Ab [Presence] in Serum

223

1336

1.70

12.28

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

178

1000

1.81

12.26

1.5

7.07

16.51

iu/ml

—

(3008898) HLA-B27 [Presence]

262

1649

1.62

11.93

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

450

3188

1.45

11.87

10.0

7.2

9.67

9.22

mmol/l

0.68

430

3041

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

114

559

2.06

11.77

1.2

1.3

0.62

0.61

nmol/l

0.06

105

539

(3034770) Mitochondria Ab [Titer] in Serum

200

1177

1.73

11.76

1.3

1.2

1093.33

964.29

titre

—

(3013293) Extractable nuclear Ab [Presence] in Serum

4.35

11.67

1.8

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

442

2.19

11.66

1.3

1.4

0.42

g/l

0.04

304

(3028192) IgG subclass 2 [Mass/volume] in Serum

442

2.19

11.66

1.3

1.4

3.21

2.93

g/l

0.69

304

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

436

3084

1.45

11.59

2.4

12.45

23.74

au/ml

3.86

261

(3042733) HLA Ab [Presence] in Serum

103

3.61

11.58

6.6

5.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

125

638

1.98

11.57

1.8

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

578

2.03

11.48

4.1

2.6

1129.44

1544.51

u/ml

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

403

2820

1.47

11.33

1.3

44.22

51.40

au/ml

0.22

164

(3027135) IgG subclass 1 [Mass/volume] in Serum

442

2.17

11.26

1.3

1.4

6.50

6.88

g/l

0.45

302

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.92

11.19

6.5

5.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1073

8772

1.28

11.19

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

206

1241

1.69

11.14

1.1

10.25

4.89

u/ml

0.32

146

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

147

804

1.85

11.08

1.4

1.2

278.43

265.54

u/ml

0.17

498

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

155

862

1.82

11.07

1.4

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

172

987

1.77

11.07

5.5

3.3

1.53

1.49

mg/l

0.24

159

911

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

108

533

2.05

10.99

1.1

1.51

g/l

0.01

478

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

247

2.57

10.98

1.5

1.7

4.86

6.17

u/l

1.70

211

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

638

4863

1.36

10.96

7.4

6.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

132

3.20

10.93

2.8

2.3

105.86

133.87

au/ml

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

839

6663

1.31

10.87

3.2

2.6

0.99

1.23

e6/l

0.75

508

3726

(3007566) Smooth muscle Ab [Titer] in Serum

193

1156

1.70

10.68

1.3

1.2

62.63

147.65

titre

0.94

(3002256) Pathology report gross observation

709

5528

1.33

10.44

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

203

1241

1.66

10.41

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

410

2927

1.44

10.37

3.6

3.4

4.41

4.46

pmol/l

0.50

361

2619

(3014765) Yersinia sp identified in Stool by Organism specific culture

204

1252

1.66

10.31

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

205

1261

1.65

10.27

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

451

3287

1.41

10.16

2.6

64.95

68.38

ml/min/173m2

1.16

201

1280

(3026782) Osmolality of Urine

955

7782

1.28

10.10

3.5

2.8

521.88

533.95

mosm/kgh2o

0.96

820

6686

(3026008) Bacteria identified in Urine by Culture

1458

12496

1.24

9.93

3.2

2.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

309

2.32

9.92

2.2

2.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

790

6297

1.30

9.89

3.9

3.3

0.81

0.82

mmol/l

0.54

733

5902

(40768446) Kidney Pathology biopsy report

146

2.96

9.86

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

494

2.00

9.47

1.3

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

101

516

1.98

9.40

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

282

1913

1.50

9.28

2.7

2.1

6415.72

5389.92

u/l

0.21

101

771

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

100

3.32

9.15

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

100

3.32

9.15

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

100

3.32

9.15

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

100

3.32

9.15

1.0

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

735

5865

1.30

9.08

2.2

2.1

29.73

29.58

0.26

706

5684

(3011412) CD3 cells [#/volume] in Blood

409

2.07

8.94

2.3

1.21

1.23

e9/l

0.08

366

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

332

2345

1.45

8.91

1.1

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

292

2012

1.48

8.90

2.4

2.1

11.76

12.03

nmol/l

0.21

260

1783

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

855

6972

1.27

8.89

1.7

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

357

2557

1.43

8.88

1.9

1.7

—

(3013512) EKG study

1321

11326

1.23

8.76

3.7

3.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

3.04

8.68

1.9

1.5

8.78

8.68

ug/l

0.05

119

(3012516) Albumin [Mass/volume] in Urine

1293

11087

1.22

8.53

3.6

3.2

661.22

348.60

mg/l

1.10

796

6911

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

254

2.34

8.50

1.6

1.4

21.15

19.29

u/ml

0.11

(3010726) Horse dander IgE Ab [Units/volume] in Serum

126

718

1.77

8.40

1.1

1.14

1.37

u/ml

0.33

320

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

174

2.60

8.16

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

222

2.40

8.13

2.5

2.7

39.46

44.82

1.19

131

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

883

7312

1.25

7.99

2.8

2.9

2.43

2.45

mmol/l

2.44

771

6440

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1335

1.55

7.97

1.9

2.3

2.86

2.94

g/l

0.53

190

1212

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

354

2.08

7.90

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

354

2.08

7.90

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

146

883

1.67

7.89

1.2

1.1

1.95

2.24

u/ml

0.17

414

(3009508) Creatinine [Moles/volume] in Urine

1387

12054

1.21

7.87

3.5

3.1

7.28

7.39

mmol/l

0.42

1199

10250

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

599

4738

1.30

7.87

2.0

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

355

2.07

7.85

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

350

2.07

7.75

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

350

2.07

7.75

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

351

2.07

7.70

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

138

831

1.68

7.60

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1423

1.52

7.59

1.9

2.3

3.79

3.65

g/l

0.57

198

1301

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1423

1.52

7.59

1.9

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1424

1.52

7.56

1.9

2.3

7.18

7.37

g/l

0.92

199

1299

(21491868) Cryoglobulin [Mass/volume] in Serum

158

2.61

7.51

1.1

1.2

—

0.15

g/l

—

(3037756) Immunofixation for Serum or Plasma

124

729

1.72

7.46

1.4

1.7

—

(3023368) Bacteria identified in Blood by Culture

1168

10043

1.21

7.32

4.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1336

11638

1.20

7.30

4.2

3.8

12.61

8.53

mg/mmol

1.17

826

7246

(40761536) Microorganisms panel - Urine sediment

467

3612

1.32

7.22

4.6

3.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

333

2.06

7.21

1.3

1.2

2.41

1.40

u/ml

0.29

174

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

288

2.13

7.11

2.4

456.06

502.87

e6/l

0.40

240

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

275

2.16

7.11

2.5

0.22

0.21

e9/l

0.08

237

(3000570) Elastase.pancreatic [Mass/mass] in Stool

181

1186

1.55

7.07

1.3

1.4

320.27

289.26

ug/g

1.16

102

667

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

134

2.70

7.07

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

145

903

1.62

7.03

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

129

780

1.67

7.02

2.2

1.9

5.27

5.14

mmol/24h

0.18

117

686

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

185

1224

1.53

6.93

2.3

2.4

0.98

0.79

g/l

0.25

165

1066

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

112

657

1.72

6.83

1.3

1.2

4.58

4.56

u/ml

0.00

273

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

355

1.99

6.77

1.4

1.5

30.98

32.60

0.13

213

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

114

674

1.71

6.76

1.3

1.2

3.95

4.01

u/ml

0.01

217

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

876

7373

1.23

6.74

3.9

3.4

214.99

393.01

ng/l

2.11

591

5334

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

7.16

6.69

2.5

3.2

1.98

2.63

mg/l

0.51

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

144

2.58

6.68

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

792

1.65

6.64

1.1

4.45

5.54

u/ml

0.33

383

(3000492) Spirometry study

521

4139

1.29

6.61

1.5

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1086

1.55

6.56

1.9

2.3

0.02

g/l

0.09

155

1004

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

286

2082

1.40

6.54

2.3

2.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

582

4707

1.27

6.39

2.9

2.6

6.85

7.24

umol/l

0.27

506

4061

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

503

3996

1.29

6.38

3.1

3.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

388

2976

1.33

6.37

2.5

2.3

8.09

6.82

ug/l

0.23

336

2626

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.74

6.35

1.0

1.1

0.02

0.04

u/ml

0.40

(3008401) Mugwort IgE Ab [Units/volume] in Serum

124

763

1.64

6.35

1.1

1.17

1.22

u/ml

0.03

298

(3000060) B lymphocytes [#/volume] in Blood

119

2.70

6.33

2.4

2.2

139.05

142.06

e6/l

0.03

(3052851) Hemolysis interference index of Serum or Plasma

178

1193

1.51

6.31

2.7

3.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

575

1.74

6.28

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

231

2.18

6.20

1.3

1.5

21.43

26.26

umol/l

0.61

219

(3037121) Protein [Mass/volume] in Urine

189

1288

1.49

6.19

3.9

3.1

0.28

0.29

g/l

0.04

496

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

193

1322

1.48

6.16

2.0

2.3

10.49

10.15

g/l

0.44

178

1190

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

646

5312

1.25

6.14

2.2

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

315

2355

1.36

6.14

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

542

1.75

6.13

1.5

1.6

—

(3045424) Erythrocytes [Presence] in Urine

113

691

1.65

5.95

1.8

1.5

—

(3019225) pH of Specimen

489

3907

1.28

5.93

4.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

284

2.02

5.84

1.1

1.00

1.04

ratio

1.60

106

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

230

1646

1.42

5.84

1.6

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

347

1.91

5.81

1.4

1.2

—

(3011985) Renin [Units/volume] in Plasma

514

1.74

5.79

1.6

1.5

81.58

46.94

mu/l

0.72

456

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

166

1118

1.50

5.78

2.9

3.4

32.23

60.94

mg/l

1.46

127

902

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

485

1.77

5.77

1.4

329.72

319.24

pmol/l

0.13

422

(3030981) Hyaline casts [#/volume] in Urine by Automated count

264

1939

1.38

5.76

2.9

2.6

0.24

0.29

e6/l

0.30

256

1872

(40760888) Immunoglobulin light chains.free panel - Serum

130

831

1.58

5.73

2.8

3.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

406

1.84

5.72

2.3

0.99

1.34

g/24h

0.63

207

(3017732) Neutrophils [#/volume] in Blood

380

2953

1.31

5.70

2.4

2.8

4.19

4.76

e9/l

0.74

315

2453

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.10

5.68

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

464

3704

1.28

5.67

2.6

2.2

0.22

0.21

g/l

0.94

429

3474

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.84

5.66

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.70

5.64

1.0

0.01

0.18

u/ml

0.69

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

316

1.94

5.62

1.3

1.2

200.00

189.57

titre

0.04

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

268

2.03

5.61

1.4

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

161

1086

1.50

5.58

2.9

3.3

1.13

1.55

ratio

1.03

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

101

611

1.67

5.57

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

419

3313

1.29

5.53

4.1

3.6

1.23

mmol/l

0.60

357

2894

(3011897) Casein IgE Ab [Units/volume] in Serum

3.34

5.43

1.1

1.2

0.19

0.10

u/ml

0.18

(3009214) Lutropin [Units/volume] in Serum or Plasma

166

1134

1.48

5.42

1.3

9.77

12.08

u/l

1.37

131

939

(3034860) Kappa light chains.free [Mass/volume] in Serum

164

1118

1.48

5.41

2.9

3.4

40.76

104.57

mg/l

0.68

123

906

(3016650) Hepatitis A virus Ab [Presence] in Serum

111

694

1.61

5.39

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

725

6121

1.22

5.35

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

188

1319

1.44

5.35

2.2

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

138

910

1.53

5.34

1.7

1.6

8224.74

11344.02

e6/l

0.47

103

661

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

413

3275

1.28

5.33

2.0

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

477

3856

1.26

5.26

2.6

2.3

45.62

37.22

u/l

0.47

408

3283

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

179

1249

1.45

5.25

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

462

1.74

5.25

1.2

—

(3024471) HLA-A [Type]

109

2.58

5.12

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

307

1.90

5.05

1.4

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

475

1.72

5.05

1.9

1.7

1216.00

1469.09

titre

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

603

5028

1.23

5.03

1.7

1.43

1.42

0.08

509

4460

(3012494) Peanut IgE Ab [Units/volume] in Serum

122

2.47

5.03

1.0

1.1

0.44

2.29

u/ml

1.01

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

492

1.70

4.98

2.4

2.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

148

1008

1.48

4.94

2.0

2.3

0.00

g/l

-0.00

137

931

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

726

6178

1.20

4.93

3.5

2.8

2.93

3.14

e6/l

0.15

393

3270

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

339

1.84

4.90

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

253

1900

1.35

4.85

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

997

1.48

4.82

2.0

2.3

0.00

g/l

-0.00

137

929

(3010144) Erythrocytes [#/volume] in Synovial fluid

341

1.83

4.81

1.4

25150.45

59254.44

e6/l

0.63

233

(3024932) HLA-DR beta [Type]

107

2.53

4.78

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

147

1007

1.47

4.78

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

218

1605

1.37

4.75

1.6

1.8

1.51

1.53

g/l

0.12

189

1380

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1124

1.45

4.75

1.9

2.2

37.94

38.03

g/l

0.06

147

998

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

139

944

1.49

4.72

1.4

273.41

1418.09

e6/l

2.31

114

758

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

177

1260

1.42

4.70

2.8

2.2

265.82

652.86

ug/l

1.41

157

1174

(3004809) Band form neutrophils/100 leukocytes in Blood

595

1.61

4.64

4.6

3.1

1.68

1.48

0.15

537

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

212

2.04

4.61

1.1

90.58

91.57

0.07

169

(3033658) Prothrombin time (PT) actual/Normal

1166

10384

1.16

4.59

4.3

3.7

92.82

92.95

0.06

1123

10116

(3023419) Bacteria identified in Sputum by Culture

574

1.61

4.57

2.6

2.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

138

944

1.47

4.54

1.3

4.54

28.02

e6/l

2.78

110

717

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

135

2.30

4.51

1.0

9.98

10.96

u/ml

0.06

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

299

1.85

4.46

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

371

2972

1.27

4.45

3.0

2.7

150.40

171.91

ng/l

0.62

332

2697

(3042111) Morphology [Interpretation] in Bone marrow Narrative

613

1.58

4.35

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

106

693

1.54

4.34

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

520

1.63

4.33

1.3

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

451

1.67

4.32

1.5

1.6

51.03

58.48

0.77

278

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

297

1.83

4.24

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

498

4146

1.22

4.23

1.8

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

508

1.62

4.22

1.3

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

501

4175

1.22

4.22

1.8

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.13

4.20

2.4

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

146

2.20

4.20

2.5

2.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

248

1.90

4.19

1.1

1.0

0.23

1.58

u/ml

0.52

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.27

4.18

1.2

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

510

1.62

4.16

1.3

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

136

947

1.45

4.12

1.3

1.2

3.66

3.73

mmol/l

0.44

129

887

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

141

2.21

4.10

1.1

1.2

90.54

90.03

0.03

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

100

654

1.54

4.10

1.1

1.0

3.58

2.96

u/ml

0.27

312

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

512

1.61

4.10

1.3

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

512

1.61

4.10

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

512

1.61

4.10

1.3

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

288

2261

1.29

4.08

7.2

24.57

24.51

mmol/l

0.11

271

2145

(3023323) Follitropin [Units/volume] in Serum or Plasma

340

2730

1.26

4.02

1.4

1.3

27.01

30.99

iu/l

1.41

292

2364

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

960

8503

1.16

4.02

5.0

4.9

2.03

2.82

ug/l

3.16

853

7617

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.90

3.99

2.4

2.2

20.39

21.29

mg/l

0.09

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

105

700

1.51

3.96

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

124

2.27

3.96

2.1

1.4

—

(3019060) Gas panel - Arterial blood

297

2357

1.28

3.88

5.0

5.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

599

1.55

3.87

2.2

2.1

5.42

6.39

umol/l

0.37

430

(3051611) Lipemic interference index of Serum or Plasma

396

1.68

3.87

2.6

3.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

158

2.10

3.87

4.2

4.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

287

2271

1.28

3.84

4.0

3.5

4.99

5.16

kpa

3.55

270

2164

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.69

3.79

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

114

782

1.47

3.76

3.8

2.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

112

766

1.47

3.75

1.4

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

121

2.24

3.73

1.0

—

(3000012) Reticulocyte production index

489

1.58

3.63

2.1

2.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

482

1.59

3.61

1.3

1.2

—

33.67

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

642

1.51

3.60

1.1

5.36

3.01

u/ml

0.78

277

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

147

1067

1.39

3.58

1.4

1.3

—

(3010503) CD19 cells [#/volume] in Blood

255

1.81

3.58

2.4

0.23

0.30

e9/l

0.22

246

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

160

1179

1.37

3.56

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2116

19835

1.12

3.55

2.6

2.5

—

(3010421) pH of Blood

141

1018

1.40

3.55

3.3

4.0

7.42

0.59

135

932

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

414

1.63

3.54

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

302

1.73

3.47

1.7

2.0

19.05

18.48

nmol/l

0.18

284

(3016502) Oxygen saturation in Arterial blood

439

3685

1.21

3.47

7.9

7.8

96.05

95.79

0.45

424

3547

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

145

2.08

3.46

1.1

89.62

89.20

0.02

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

519

1.55

3.46

1.9

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

280

1.76

3.46

1.1

1.0

5.07

0.94

u/ml

0.45

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

173

1298

1.34

3.44

2.7

2.2

93.27

93.03

0.05

157

1252

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

667

1.48

3.40

1.1

—

(3009343) pH of Capillary blood

280

2246

1.26

3.39

4.0

3.5

7.42

7.41

0.33

300

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

669

1.47

3.35

1.9

1.7

—

(3036489) Thrombin time

200

1539

1.31

3.35

2.5

2.0

21.09

21.24

0.12

159

1326

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

271

2169

1.26

3.34

3.9

3.4

0.94

1.80

mmol/l

3.13

184

1615

(3045414) Leukocytes [Presence] in Urine

241

1902

1.28

3.33

2.1

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

148

2.03

3.30

1.7

1.3

71.28

125.66

nmol/24h

0.66

148

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.54

3.29

2.1

7.8

71.58

68.10

0.20

(3020874) Milk IgE Ab [Units/volume] in Serum

278

1.73

3.25

1.1

0.52

2.56

u/ml

0.90

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

159

1189

1.35

3.25

3.2

2.5

175.96

184.38

0.61

148

1137

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

146

1078

1.37

3.24

1.4

1.3

450.19

509.02

mg/l

1.49

139

1022

(3020891) Body temperature

189

1451

1.31

3.23

4.8

4.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

264

1.75

3.22

1.2

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.51

3.20

1.1

1.0

0.02

1.51

u/ml

0.63

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

235

1.79

3.20

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

583

5057

1.17

3.19

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

644

1.47

3.18

1.1

117.89

117.86

0.00

588

(3023430) Cat dander IgE Ab [Units/volume] in Serum

595

1.49

3.18

1.1

7.24

3.34

u/ml

0.98

216

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

266

1.74

3.15

1.2

1.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

485

4151

1.19

3.12

7.4

7.3

12.34

12.56

kpa

0.43

461

3965

(3003396) Base excess in Arterial blood by calculation

484

4142

1.19

3.12

7.4

0.99

1.07

mmol/l

0.17

367

3268

(3019832) Treponema pallidum Ab [Presence] in Serum

520

4483

1.18

3.07

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

207

1623

1.29

3.04

1.6

254.18

299.78

mu/l

2.67

190

1449

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

675

1.45

3.04

1.3

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

484

4151

1.18

3.04

7.4

7.3

5.05

5.09

kpa

0.57

458

3963

(21494890) Protein electrophoresis panel - 24 hour Urine

361

1.61

3.03

1.7

2.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.55

2.98

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

162

1.92

2.94

1.1

—

(21494434) Karyotype in Bone marrow

310

1.65

2.93

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

121

883

1.38

2.92

1.3

—

(3028433) Virus identified in Specimen by Culture

135

2.01

2.90

1.1

1.2

—

(3045142) Bone marrow Pathology biopsy report

429

1.55

2.89

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

387

3274

1.20

2.85

6.6

3.7

5.81

5.84

kpa

0.28

378

3169

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

164

1.90

2.84

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

635

1.44

2.84

1.3

1.4

61.27

63.70

mmol/l

0.22

514

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

270

2206

1.24

2.83

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.23

2.79

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

137

1.98

2.79

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

425

1.54

2.79

2.0

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

215

1715

1.27

2.78

1.7

3.78

3.83

mg/l

0.03

176

1259

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.55

2.78

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

761

6803

1.14

2.77

4.6

4.2

22.66

21.64

1.08

361

3289

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

157

1204

1.31

2.76

4.2

2.5

3.30

3.60

g/l

2.26

149

1137

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

126

936

1.36

2.74

1.9

1.6

—

(3003338) MCHC [Mass/volume]

3747

36438

1.11

2.74

21.0

16.4

332.20

331.98

g/l

0.80

3729

36186

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

153

1171

1.32

2.73

2.7

2.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

194

1534

1.28

2.71

1.3

166.11

221.44

miu/ml

1.65

745

(3002173) Hemoglobin [Mass/volume] in Arterial blood

402

3430

1.19

2.71

8.4

8.2

121.45

121.52

g/l

0.02

391

3332

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

279

1.65

2.70

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

132

1.97

2.69

1.1

1.0

—

(1616796) Gas panel - Central venous blood

115

845

1.37

2.69

3.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.00

2.69

1.1

—

3.00

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

140

1.93

2.64

1.7

2.1

1.11

1.13

ug/l

0.01

131

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.21

2.63

1.3

1.1

103.40

77.77

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

529

1.46

2.63

1.1

1.0

0.30

0.28

u/ml

0.03

128

(3034891) Synovial lining cells/100 cells in Synovial fluid

191

1.79

2.61

1.4

4.86

3.59

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.46

2.61

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

191

2385

0.79

2.56

1.5

—

(3049717) Cytology report of Urine Cyto stain

160

1248

1.29

2.51

2.7

2.5

—

(4281824) Cell count and differential, peritoneal fluid

512

0.56

2.51

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

112

830

1.36

2.51

1.4

28.83

29.34

u/l

0.05

680

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

270

1.64

2.49

1.0

0.92

1.12

u/l

4.63

127

(3038177) Helicobacter pylori Ab [Presence] in Serum

106

780

1.37

2.48

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

365

1.54

2.47

4.2

3.0

56.49

34.88

mg/l

0.40

267

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

202

1625

1.25

2.47

6.6

2.7

0.63

0.65

0.28

202

1611

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

271

1.63

2.46

1.7

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.39

2.46

1.5

1.4

90.39

110.99

ng/l

0.37

(3047007) Chlamydophila sp Ab [Presence] in Serum

646

1.40

2.45

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

170

1341

1.28

2.45

1.5

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

455

1.48

2.45

4.3

4.9

72.83

66.16

u/ml

0.06

137

(3006922) Hepatitis E virus Ab [Presence] in Serum

287

1.61

2.44

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

287

1.61

2.44

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.14

2.44

1.2

1.1

97.00

71.09

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

464

1.47

2.43

2.4

2.3

—

(3047181) Lactate [Moles/volume] in Blood

155

1210

1.29

2.43

6.6

6.4

1.31

1.25

mmol/l

0.47

142

1057

(3048879) Bone marrow aspiration report

2.09

2.42

1.8

1.9

—

(3012501) Base excess in Blood by calculation

116

870

1.34

2.42

3.5

4.1

2.09

2.53

mmol/l

1.13

591

(3051651) Icteric interference index of Serum or Plasma

234

1.67

2.41

2.7

3.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

116

871

1.34

2.40

3.5

4.1

4.93

5.03

kpa

0.94

116

858

(3042631) Mycobacterium sp identified in Specimen

490

1.46

2.40

2.9

2.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

117

1.97

2.40

1.5

1.3

43.63

51.08

0.45

101

(3044941) Cell count panel - Synovial fluid

617

1.40

2.36

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

467

1.46

2.36

2.1

23.27

22.86

mg/l

0.03

123

(3036525) Urea [Moles/time] in 24 hour Urine

4.12

2.36

2.3

2.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

374

3215

1.18

2.34

8.9

6.8

1.28

1.35

mmol/l

0.73

362

3138

(21494814) CD8 cells/100 lymphocytes in Specimen

169

1.78

2.32

1.8

1.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

199

1.71

2.31

1.4

1.3

4.19

4.54

umol/l

0.29

187

(3027315) Oxygen [Partial pressure] in Blood

116

877

1.33

2.31

3.5

4.1

8.92

8.63

kpa

1.16

116

863

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

276

1.60

2.31

2.0

1.6

—

(3008295) Osmolality of Serum or Plasma

396

1.50

2.30

1.4

280.51

279.04

mosm/kgh2o

0.19

306

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

148

1.83

2.28

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

120

914

1.32

2.27

1.9

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1093

0.72

2.26

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

127

1.89

2.25

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1055

0.72

2.23

1.5

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.10

2.22

1.2

1.0

8.09

6.86

mg/g

0.34

(3030313) Adrenal Ab [Titer] in Serum

2.86

2.20

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1052

0.72

2.19

1.5

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

210

1.67

2.19

1.1

8.57

7.48

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.03

2.15

1.2

34.82

37.97

g/l

0.30

(3016018) Differential panel - Cerebral spinal fluid

460

1.44

2.15

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

203

1663

1.23

2.15

6.5

2.8

1.20

1.24

0.18

203

1647

(3022313) Gas panel - Capillary blood

199

1627

1.23

2.15

4.4

3.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.00

2.14

1.6

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.17

2.14

1.9

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

554

4938

1.14

2.14

4.5

4.3

32.73

32.53

0.17

420

3409

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.45

2.10

1.1

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

102

769

1.33

2.10

3.7

2.8

36.00

35.59

umol/l

0.06

703

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

112

856

1.32

2.10

2.5

2.3

49.84

82.46

ug/min

0.98

523

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

530

1.40

2.09

1.7

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

348

1.50

2.08

1.1

222.21

245.82

mg/l

0.66

305

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

641

1.36

2.08

1.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

641

1.36

2.08

1.9

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

229

1.62

2.07

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

183

1.70

2.07

1.1

138.67

166.81

iu/ml

0.60

183

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

650

1.36

2.07

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

106

1382

0.76

2.07

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.00

2.07

4.4

2.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.00

2.07

5.2

5.4

317.40

347.00

umol/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

2.07

4.2

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

313

2682

1.18

2.07

6.2

3.0

4.60

4.61

kpa

0.02

305

2591

(3025549) Creatine [Moles/time] in 24 hour Urine

2.91

2.07

1.1

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

659

1.36

2.06

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

259

2186

1.19

2.04

6.6

3.1

130.81

129.00

g/l

0.71

252

2126

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

575

1.38

2.04

1.2

20.26

31.97

u/l

1.44

499

(3002079) Sodium [Moles/time] in 24 hour Urine

177

1.70

2.01

1.5

1.3

157.50

150.82

mmol/24h

0.19

177

(3002032) Base excess in Venous blood by calculation

376

3277

1.16

2.01

6.7

3.7

1.64

1.96

mmol/l

1.03

327

2787

(3023410) Appearance of Cerebral spinal fluid

442

1.43

2.01

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

173

1406

1.24

2.00

4.5

3.7

24.28

24.88

mmol/l

2.19

160

1309

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

360

1.48

1.99

1.2

1.1

32.17

38.91

mg/l

0.89

305

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

436

1.43

1.96

2.0

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

436

1.43

1.96

2.0

1.4

—

(3000991) Gas panel - Venous blood

346

3004

1.16

1.96

10.5

8.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

504

1.39

1.94

1.6

1.8

90.44

89.91

0.45

496

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.55

1.94

3.8

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

904

1.29

1.91

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

113

1.86

1.91

2.6

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

364

1.46

1.90

3.8

3.0

57.43

57.25

0.02

315

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

144

1154

1.26

1.90

3.0

3.2

0.35

u/ml

0.10

662

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

544

0.64

1.89

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.16

1.87

2.4

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.31

1.87

2.0

1.5

—

(40765096) Chromosome analysis panel by Banding

114

1.85

1.86

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

510

4574

1.13

1.81

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

393

1.43

1.81

2.4

4.9

7.22

7.18

mmol/l

0.03

328

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

264

2260

1.18

1.80

8.7

7.1

24.67

24.87

mmol/l

0.47

264

2246

(3016228) CD19 cells/100 cells in Blood

176

1.65

1.79

1.9

11.14

8.20

0.48

169

(3039000) Anion gap in Blood

106

825

1.29

1.78

7.8

7.9

11.29

11.12

mmol/l

0.27

733

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

184

1526

1.21

1.78

2.0

1.9

—

(3018572) Chloride [Moles/volume] in Blood

106

826

1.29

1.77

7.8

104.80

105.23

mmol/l

0.41

734

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

337

1.46

1.76

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

124

1.78

1.75

3.0

2.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

679

1.32

1.74

1.8

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

102

793

1.29

1.74

2.3

2.4

16.61

16.30

0.27

395

(3007930) Methemoglobin/Hemoglobin.total in Blood

175

1449

1.22

1.73

5.9

5.7

0.90

0.91

0.05

162

1350

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

209

1.58

1.73

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

132

1.75

1.73

2.0

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

545

4923

1.12

1.73

3.1

3.0

0.75

0.76

ug/l

0.08

358

3272

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.92

1.72

1.0

0.04

0.29

u/ml

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.85

1.71

2.0

3.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

101

1285

0.78

1.69

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

357

1.43

1.69

1.2

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

142

1154

1.24

1.69

2.0

2.76

4.57

iu/l

3.87

454

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

101

1283

0.78

1.67

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

101

1283

0.78

1.67

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

392

1.41

1.66

4.1

3.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

180

1.61

1.66

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

180

1.61

1.66

1.7

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.10

1.65

1.0

1.1

—

(3017704) Immunofixation for Urine

196

1.59

1.65

1.7

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

142

1.69

1.64

1.6

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

101

1278

0.79

1.63

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

766

1.28

1.62

3.1

2.0

0.83

0.82

nmol/l

0.09

649

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

175

1460

1.21

1.62

5.9

5.5

1.67

1.62

0.27

161

1355

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

135

1.71

1.62

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

135

1.71

1.62

3.1

2.8

28.35

29.00

umol/l

0.11

(3016038) Potassium [Moles/volume] in Urine

237

1.52

1.62

1.1

33.86

35.04

mmol/l

0.09

208

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

143

1.68

1.60

2.5

2.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

506

1.35

1.60

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

304

1.45

1.58

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

263

1.49

1.57

1.3

—

(3024263) Appearance of Synovial fluid

208

1.54

1.53

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

589

1.31

1.52

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

299

1.44

1.50

6.2

6.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.50

2.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

2.16

1.50

3.1

2.2

70.17

72.17

pmol/l

0.03

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

374

4185

0.89

1.50

1.6

1.7

—

(3024928) Oxygen saturation in Venous blood

785

1.27

1.49

9.2

2.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

334

1.41

1.47

1.5

1.3

1.66

1.47

nmol/l

0.55

304

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

138

1138

1.22

1.47

1.8

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

109

1.75

1.46

1.1

1.3

132.03

132.00

nmol/l

0.00

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.22

1.46

14.1

12.2

5.02

5.76

mmol/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

102

1.77

1.44

1.0

2.0

3.45

2.00

ug/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.88

1.44

1.5

1.2

0.78

83.72

mg/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

430

1.35

1.42

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

195

1669

1.18

1.40

4.8

3.2

25.01

25.34

mmol/l

0.66

188

1604

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

1.58

1.40

4.1

3.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

226

1959

1.16

1.38

10.5

10.0

—

(3044640) Blood type and Crossmatch panel - Blood

1389

13227

1.07

1.35

2.4

2.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

183

1.53

1.34

9.5

5.2

31.00

60.60

u/ml

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.14

1.33

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.91

1.33

1.0

1.5

—

(3021901) Oxygen saturation in Capillary blood

655

1.27

1.33

2.9

2.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.97

1.32

1.3

87.83

40.23

ng/l

—

(3044927) Protein electrophoresis panel - Urine

359

1.37

1.31

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.30

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.50

1.30

1.7

266.17

334.96

umol/24h

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

217

1.48

1.30

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

343

1.37

1.29

3.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

774

1.25

1.29

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

774

1.25

1.29

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

438

1.33

1.29

1.2

55.83

56.92

u/l

0.07

400

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.78

1.28

2.0

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

250

2836

0.88

1.28

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.05

1.26

1.6

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

211

1.47

1.25

1.1

1854.97

1467.04

miu/ml

1.11

211

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

303

1.39

1.25

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

301

2685

1.13

1.24

2.1

3.4

38.53

49.70

u/ml

0.70

287

2591

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

270

1.41

1.23

1.7

1.5

5.91

6.15

u/l

0.05

225

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

253

0.59

1.23

1.2

1.1

—

(3022621) pH of Urine by Test strip

302

2697

1.13

1.23

3.1

2.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.77

1.22

1.0

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

155

1.55

1.22

1.8

1.4

14.25

14.55

pmol/l

0.15

131

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

755

1.24

1.20

1.8

1.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.75

1.18

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

341

1.35

1.17

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

341

1.35

1.17

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

341

1.35

1.17

1.5

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

641

1.25

1.16

1.1

65.40

15622.14

iu/ml

0.53

150

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

1.16

1.2

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

1.44

1.15

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

135

1586

0.85

1.13

1.3

1.4

—

(40768800) Prostate Pathology biopsy report

529

0.74

1.13

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

466

1.29

1.12

1.1

—

85.00

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.00

1.12

2.3

2.1

—

(21494755) Public health laboratory ask at order entry panel

413

4509

0.91

1.11

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.26

1.10

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.38

1.09

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.38

1.09

1.8

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.38

1.09

1.0

—

(3019174) dRVVT (LA screen)

1.95

1.08

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

144

1.53

1.08

1.1

5.7

51.07

66.35

mg/l

1.07

103

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

506

1.27

1.06

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

211

1.42

1.05

1.6

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

288

1.36

1.04

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.79

1.04

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.79

1.04

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.79

1.04

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.27

1.03

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.63

1.03

1.1

—

288.00

—

(3036180) Methadone [Presence] in Urine

178

0.56

1.03

1.5

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

688

0.78

1.02

1.3

2.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

483

1.27

1.01

1.1

—

3.87

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

163

1420

1.15

1.00

2.0

2.43

2.26

ug/l

0.05

144

1266

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

205

1.42

1.00

2.1

1.7

1.29

2.66

u/field

0.83

144

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.65

1.00

1.5

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.88

1.00

1.4

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.71

0.98

3.2

2.0

—

(1002224) Polysomnography panel

203

1800

1.13

0.97

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

249

1.37

0.97

1.2

1.1

82.69

83.43

u/l

0.02

220

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

184

1622

1.14

0.97

1.8

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.74

0.96

1.1

1.0

0.42

5.06

u/ml

0.66

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

241

1.37

0.96

1.2

1.1

13.96

21.54

u/l

0.94

208

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

267

1.35

0.95

1.1

3.42

6.71

nmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

425

1.27

0.95

1.1

—

(4035726) Immunohistochemistry procedure

400

3688

1.09

0.94

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

1.89

0.94

1.0

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

471

1.26

0.93

6.4

6.6

11.17

11.57

mg/l

0.35

439

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

1.56

0.93

2.0

3.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

1.56

0.93

2.0

3.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

437

1.26

0.91

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

745

1.20

0.91

1.7

1.8

—

(1761868) Lipid panel - Serum or Plasma

1632

15784

1.05

0.91

3.0

2.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

837

1.19

0.91

1.9

2.2

129.21

g/l

0.00

619

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.63

0.90

1.1

0.59

0.68

umol/24h

—

(3002619) Bacteria identified in Specimen by Culture

1.63

0.90

1.4

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

210

1.38

0.90

2.0

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.75

0.90

1.5

2.8

—

(3000330) Specific gravity of Urine by Test strip

175

1972

0.88

4.3

3.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1152

0.85

0.88

1.4

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

291

1.31

0.84

1.1

7.44

10.44

iu/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.94

0.84

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

248

1.33

0.83

1.1

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

166

1473

1.13

0.82

1.7

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

319

0.72

0.82

1.7

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

390

1.26

0.82

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

873

0.83

0.81

1.4

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

105

1.53

0.81

1.2

1.4

—

(40768441) Liver Pathology biopsy report

311

1.29

0.80

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.70

0.80

1.1

1.54

1.66

umol/24h

—

(3000093) Morphology [Interpretation] in Blood Narrative

329

1.28

0.80

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

123

1073

1.15

0.79

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

208

1877

1.11

0.79

1.3

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.79

0.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.59

0.78

2.9

2.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

122

0.57

0.77

2.6

3.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

243

1.32

0.77

1.6

1.5

—

(40768793) Breast Pathology biopsy report

132

1161

1.14

0.76

1.2

1.3

—

(3001729) Color of Synovial fluid

1.77

0.76

1.8

1.5

—

(3001556) Androgen free Index in Serum or Plasma

1.77

0.76

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.57

0.74

11.2

7.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

315

1.27

0.74

1.5

1.6

1.36

1.22

promille

0.24

237

(3003740) Influenza virus B Ag [Presence] in Specimen

716

1.18

0.74

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

396

1.24

0.74

1.6

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

717

1.17

0.73

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

167

1.38

0.73

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

167

1.38

0.73

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

254

1.30

0.73

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

100

1.50

0.72

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

129

1458

0.88

0.72

1.2

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

803

1.16

0.71

2.3

3.5

99.60

686.66

u/ml

1.11

740

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

1.40

0.70

1.1

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.71

0.70

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

204

1.33

0.68

1.1

—

(3018133) Calcium [Moles/volume] in Urine

1.53

0.68

2.2

1.9

2.65

2.70

mmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

108

1227

0.88

0.67

1.3

1.9

—

(4034850) Laboratory test

150

1346

1.12

0.66

10.5

9.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.54

0.65

11.9

7.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.59

0.65

1.3

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.61

0.65

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

103

1.46

0.64

1.3

1.2

—

(3011648) Oxygen content in Venous blood

304

1.25

0.64

8.7

2.4

11.38

11.22

0.09

304

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

304

1.25

0.64

2.6

1.7

—

(3019977) pH of Arterial blood

198

1.31

0.64

1.8

3.4

7.42

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

1.40

0.63

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

234

1.28

0.62

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

461

1.20

0.61

1.1

—

(3016750) Collection duration of Urine

217

1.29

0.61

2.4

2.2

489.05

495.72

min

0.17

161

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

1.42

0.61

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

122

1089

1.12

0.60

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

105

1.43

0.60

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1024

0.88

0.59

1.6

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

724

1.15

0.59

1.6

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.58

0.0

1.1

—

37.10

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.58

0.0

1.1

—

20.57

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.58

0.0

1.1

—

7.94

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

282

1.24

0.58

1.3

1.5

78.20

77.41

umol/l

0.06

282

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

275

0.76

0.56

1.3

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.56

1.8

1.5

42.17

42.36

umol/l

—

(3034426) Prothrombin time (PT)

150

1.33

0.55

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

150

1.33

0.55

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.55

1.2

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

114

1021

1.12

0.55

1.6

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.45

0.55

1.7

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

222

1.26

0.53

1.3

1.4

142.79

132.64

nmol/l

0.43

222

(3001019) Free T4 and TSH panel - Serum or Plasma

292

2739

1.07

0.52

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

268

1.23

0.52

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

143

1.33

0.52

1.6

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.50

0.51

1.7

1.1

—

(3014891) Appearance of Pleural fluid

1.46

0.50

2.0

1.3

—

(3035880) pH of Pleural fluid

180

1.28

0.49

1.3

1.4

—

(3025577) Chromium [Mass/volume] in Blood

216

1.25

0.49

2.2

2.0

3.92

2.52

ug/l

0.78

183

(3014271) Vancomycin [Susceptibility]

154

1.30

0.48

2.8

2.9

—

(3047189) Immunofixation for 24 hour Urine

181

1.27

0.48

1.4

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

786

1.12

0.47

1.2

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.41

0.46

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.43

0.45

1.5

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

856

1.11

0.44

3.7

3.2

24.13

25.60

mg/l

0.15

527

(3024869) Neuronal Ab [Presence] in Serum

1.45

0.44

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

146

1581

0.92

0.43

1.2

1.9

—

(4212803) Bone marrow aspirate examination

1.61

0.43

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

162

0.74

0.42

2.6

2.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.56

0.42

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

642

1.12

0.41

1.2

1.4

2.43

3.85

ug/l

1.96

570

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

249

1.21

0.41

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.36

0.41

9.4

7.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.40

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.40

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.40

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.40

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.47

0.40

1.2

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.40

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.43

0.39

2.4

1.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

203

1907

1.07

0.39

9.9

9.3

24.15

24.31

mmol/l

0.29

197

1858

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.38

0.38

2.5

1.3

—

(3042517) Benzodiazepines panel - Urine

1.35

0.37

1.0

2.1

—

(40758292) HTLV I+II Ab panel - Serum

1.30

0.37

1.2

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

161

1.24

0.37

9.1

9.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

207

1.21

0.36

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

207

1.21

0.36

1.6

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

217

1.20

0.35

1.4

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.34

0.34

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.34

0.34

1.7

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

163

1.23

0.34

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

349

1.15

0.33

1.5

12435.54

89236.16

e6/l

2.47

204

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

414

0.87

0.33

1.8

1.9

14.37

24.95

ug/l

2.59

408

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.30

0.33

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

285

0.84

0.32

1.1

1.3

1.51

1.59

g/l

0.73

285

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

369

1.14

0.32

1.2

1.4

8.21

8.44

mmol/l

0.15

360

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

398

1.13

0.32

1.2

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

174

1.21

0.31

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

150

1595

0.94

0.31

1.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

147

1564

0.94

0.31

1.2

1.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.71

0.30

1.1

50.69

54.69

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.30

0.30

1.3

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.30

0.30

3.1

6.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.27

0.30

4.6

1.7

—

(3027008) Opiates [Presence] in Urine

150

1591

0.94

0.29

1.2

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

222

1.17

0.29

1.4

1.3

—

(3004775) Volume in Urine collected for unspecified duration

288

1.15

0.29

2.6

2.3

705.13

622.68

0.45

194

(3005011) Chlamydia sp Ab [Titer] in Serum

1.23

0.27

2.0

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

499

0.90

0.26

1.7

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.68

0.26

1.4

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

192

0.83

0.25

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

106

1129

0.94

0.25

3.2

2.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

179

1.17

0.25

1.2

1.4

208.24

206.92

pmol/l

0.01

179

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

223

0.85

0.24

1.1

1.3

—

(40757373) Influenza virus identified in Isolate

1.17

0.24

3.0

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

900

0.93

0.24

5.0

4.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

208

1.15

0.24

1.8

1.4

1.18

1.25

nmol/l

0.10

167

(3044242) Glucose [Moles/volume] in Arterial blood

180

1.17

0.23

2.0

2.1

—

(3017569) Oxygen content in Arterial blood

171

1.17

0.23

1.7

2.2

—

(3012898) Urea [Moles/volume] in Urine

1.28

0.23

1.0

1.4

154.40

154.24

mmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

1.28

0.23

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.28

0.23

1.4

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

227

2185

1.04

0.22

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

114

1078

1.06

0.22

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

410

0.90

0.22

4.0

2.3

106.54

105.35

mmol/l

0.91

403

(3041354) Potassium [Moles/volume] in Venous blood

410

0.90

0.22

4.0

2.3

3.96

4.01

mmol/l

0.34

403

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.22

0.22

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

343

1.11

0.22

1.2

1.1

320.57

384.09

nmol/l

1.40

307

(3044007) Cell count panel - Peritoneal fluid

107

1.22

0.21

2.2

2.1

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

2.54

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3008607) Semen analysis panel

0.00

0.21

0.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

553

0.92

0.20

3.9

5.3

341.67

368.46

umol/l

0.65

478

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.20

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.20

1.3

1.1

—

(3020491) Glucose [Moles/volume] in Blood

298

1.11

0.19

2.4

1.6

7.09

6.53

mmol/l

0.47

200

(3028717) Thiamine [Mass/volume] in Blood

1.18

0.19

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

510

1.08

0.19

1.7

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.13

0.18

4.0

8.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

301

0.90

0.18

2.2

2.0

2.71

1.77

u/field

0.54

128

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.21

0.18

1.6

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

119

1.18

0.17

1.7

2.0

3655.75

20973.90

e6/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.75

0.17

1.2

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.19

0.16

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1017

10045

1.02

0.16

2.3

2.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

244

1.11

0.16

1.0

310.26

336.16

ng/l

0.17

168

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

143

1377

1.04

0.16

3.2

3.3

87.85

1807.43

u/ml

1.25

122

1168

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

808

1.05

0.16

1.4

0.34

0.40

nmol/l

0.56

624

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

1.17

0.15

1.5

1.2

—

(3033799) Differential panel - Peritoneal fluid

111

1.17

0.15

2.6

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

168

1.13

0.15

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.77

0.15

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

245

1.10

0.15

1.0

645.89

726.67

ng/l

0.44

165

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.08

0.14

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.80

0.14

2.6

2.0

12.96

17.41

umol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

399

0.93

0.14

4.0

2.3

—

(3012441) Differential panel - Pleural fluid

324

1.08

0.14

1.7

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.19

0.14

1.6

1.2

4.76

407.55

ug/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

400

4074

0.98

0.13

3.1

3.9

9.77

30.50

ug/l

1.32

308

3219

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

247

1.09

0.13

1.0

45.53

45.76

ng/l

0.01

166

(3023383) Lactate [Moles/volume] in Pleural fluid

108

0.83

0.13

1.8

1.4

2.90

3.23

mmol/l

—

(40768806) Pleura Pathology biopsy report

345

0.93

0.12

1.7

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

395

0.94

0.12

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

396

1.06

0.11

1.6

1.5

1949.56

2294.69

e6/l

0.23

290

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

357

1.06

0.11

2.9

2.7

—

(3011288) Drugs identified in Urine by Screen method

106

1095

0.97

0.10

1.4

2.6

—

(3006462) Nitrate [Presence] in Urine

208

0.91

0.10

4.6

3.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.14

0.10

2.2

2.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

727

0.96

0.09

1.4

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.06

0.09

9.6

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.06

0.09

4.8

2.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

339

0.94

0.08

1.5

0.86

0.96

g/l

2.00

339

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

1.12

0.08

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

127

1.10

0.07

1.4

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

256

0.94

0.07

1.0

1.4

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.84

0.07

1.0

1.1

—

4.68

—

(40765089) Chromosome analysis panel - Blood by G-banded

118

1.10

0.07

1.1

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

206

1.07

0.07

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.86

0.06

1.4

1.3

—

(4146454) Self-monitoring of blood glucose

394

0.96

0.05

2.8

—

(3003694) ABO and Rh group [Type] in Blood

1200

12046

0.99

0.05

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

0.92

0.05

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

635

1.02

0.04

1.3

1.4

7.42

7.20

mmol/l

0.18

568

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

270

1.04

0.03

1.2

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

178

0.95

0.02

1.3

2.2

112.62

154.41

umol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

113

1.06

0.01

1.5

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.02

0.00

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

318

1.01

0.00

1.4

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

165

1.03

0.00

1.8

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

165

1.03

0.00

1.8

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

598

1.00

0.00

3.1

3.2

0.81

0.82

nmol/l

0.10

457

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

116

1.03

0.00

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

116

1.03

0.00

1.2

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

196

1.02

0.00

1.2

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

167

1.02

0.00

1.9

—

(40768795) Lymph node Pathology biopsy report

413

0.99

0.00

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

301

1.00

0.00

3.0

2.4

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.2

—

36.93

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.0

—

6.40

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.91

-0.00

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.01

-0.00

2.4

3.2

53.29

1558.27

u/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.85

-0.00

1.2

1.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.8

—

(3004451) EKG impression Narrative

180

1.00

-0.00

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.1

—

69.09

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3002022) Protein C Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

57.20

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.94

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_ROSACEA – Rosacea

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Rosacea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Rosacea (L12_ROSACEA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints